
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Unique Phenotypes With Corresponding Pathology in Late-Onset Hereditary Transthyretin Amyloidosis of A97S vs. V30M - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="DB2B0C71925FBB633C0C71002EC97065.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="frontagineuro">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8826435/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Frontiers in Aging Neuroscience">
<meta name="citation_title" content="Unique Phenotypes With Corresponding Pathology in Late-Onset Hereditary Transthyretin Amyloidosis of A97S vs. V30M">
<meta name="citation_author" content="Hsueh-Wen Hsueh">
<meta name="citation_author_institution" content="Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan">
<meta name="citation_author_institution" content="Department of Anatomy and Cell Biology, National Taiwan University College of Medicine, Taipei, Taiwan">
<meta name="citation_author" content="Chi-Chao Chao">
<meta name="citation_author_institution" content="Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan">
<meta name="citation_author" content="Koping Chang">
<meta name="citation_author_institution" content="Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan">
<meta name="citation_author" content="Yung-Ming Jeng">
<meta name="citation_author_institution" content="Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan">
<meta name="citation_author" content="Masahisa Katsuno">
<meta name="citation_author_institution" content="Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan">
<meta name="citation_author" content="Haruki Koike">
<meta name="citation_author_institution" content="Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan">
<meta name="citation_author" content="Sung-Tsang Hsieh">
<meta name="citation_author_institution" content="Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan">
<meta name="citation_author_institution" content="Department of Anatomy and Cell Biology, National Taiwan University College of Medicine, Taipei, Taiwan">
<meta name="citation_author_institution" content="Graduate Institute of Brain and Mind Sciences, National Taiwan University College of Medicine, Taipei, Taiwan">
<meta name="citation_author_institution" content="Center of Precision Medicine, National Taiwan University College of Medicine, Taipei, Taiwan">
<meta name="citation_publication_date" content="2022 Jan 26">
<meta name="citation_volume" content="13">
<meta name="citation_firstpage" content="786322">
<meta name="citation_doi" content="10.3389/fnagi.2021.786322">
<meta name="citation_pmid" content="35153720">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8826435/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8826435/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8826435/pdf/fnagi-13-786322.pdf">
<meta name="description" content="Hereditary transthyretin amyloidosis (ATTRv) encompasses different phenotypes among various genotypes. The analysis of the natural history and risk factors of faster progression in different genotypes would refine the treatment strategy. The ...">
<meta name="og:title" content="Unique Phenotypes With Corresponding Pathology in Late-Onset Hereditary Transthyretin Amyloidosis of A97S vs. V30M">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Hereditary transthyretin amyloidosis (ATTRv) encompasses different phenotypes among various genotypes. The analysis of the natural history and risk factors of faster progression in different genotypes would refine the treatment strategy. The ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8826435/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="8826435">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.3389/fnagi.2021.786322"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/fnagi-13-786322.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC8826435%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/8826435/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/8826435/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC8826435/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-frontagineuro.gif" alt="Frontiers in Aging Neuroscience logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Frontiers in Aging Neuroscience" title="Link to Frontiers in Aging Neuroscience" shape="default" href="http://frontiersin.org/aging%20neuroscience" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Front Aging Neurosci</button></div>. 2022 Jan 26;13:786322. doi: <a href="https://doi.org/10.3389/fnagi.2021.786322" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.3389/fnagi.2021.786322</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Front%20Aging%20Neurosci%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Front%20Aging%20Neurosci%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Front%20Aging%20Neurosci%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Front%20Aging%20Neurosci%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Unique Phenotypes With Corresponding Pathology in Late-Onset Hereditary Transthyretin Amyloidosis of A97S vs. V30M</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hsueh%20HW%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Hsueh-Wen Hsueh</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Hsueh-Wen Hsueh</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan</div>
<div class="p">
<sup>2</sup>Department of Anatomy and Cell Biology, National Taiwan University College of Medicine, Taipei, Taiwan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hsueh%20HW%22%5BAuthor%5D" class="usa-link"><span class="name western">Hsueh-Wen Hsueh</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chao%20CC%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Chi-Chao Chao</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Chi-Chao Chao</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chao%20CC%22%5BAuthor%5D" class="usa-link"><span class="name western">Chi-Chao Chao</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chang%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Koping Chang</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Koping Chang</span></h3>
<div class="p">
<sup>3</sup>Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chang%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Koping Chang</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jeng%20YM%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Yung-Ming Jeng</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Yung-Ming Jeng</span></h3>
<div class="p">
<sup>3</sup>Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jeng%20YM%22%5BAuthor%5D" class="usa-link"><span class="name western">Yung-Ming Jeng</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Katsuno%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Masahisa Katsuno</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Masahisa Katsuno</span></h3>
<div class="p">
<sup>4</sup>Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Katsuno%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Masahisa Katsuno</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Koike%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Haruki Koike</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Haruki Koike</span></h3>
<div class="p">
<sup>4</sup>Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Koike%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Haruki Koike</span></a>
</div>
</div>
<sup>4,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hsieh%20ST%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Sung-Tsang Hsieh</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Sung-Tsang Hsieh</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan</div>
<div class="p">
<sup>2</sup>Department of Anatomy and Cell Biology, National Taiwan University College of Medicine, Taipei, Taiwan</div>
<div class="p">
<sup>5</sup>Graduate Institute of Brain and Mind Sciences, National Taiwan University College of Medicine, Taipei, Taiwan</div>
<div class="p">
<sup>6</sup>Center of Precision Medicine, National Taiwan University College of Medicine, Taipei, Taiwan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hsieh%20ST%22%5BAuthor%5D" class="usa-link"><span class="name western">Sung-Tsang Hsieh</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>5,</sup><sup>6,</sup><sup>*</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan</div>
<div id="aff2">
<sup>2</sup>Department of Anatomy and Cell Biology, National Taiwan University College of Medicine, Taipei, Taiwan</div>
<div id="aff3">
<sup>3</sup>Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan</div>
<div id="aff4">
<sup>4</sup>Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan</div>
<div id="aff5">
<sup>5</sup>Graduate Institute of Brain and Mind Sciences, National Taiwan University College of Medicine, Taipei, Taiwan</div>
<div id="aff6">
<sup>6</sup>Center of Precision Medicine, National Taiwan University College of Medicine, Taipei, Taiwan</div>
<div class="author-notes p">
<div class="fn" id="fn1"><p>Edited by: Wenquan Zou, Case Western Reserve University, United States</p></div>
<div class="fn" id="fn2"><p>Reviewed by: YoTsen Liu, Taipei Veterans General Hospital, Taiwan; Eyas M. Hattab, University of Louisville, United States</p></div>
<div class="fn" id="c001">
<sup>✉</sup><p class="display-inline">*Correspondence: Haruki Koike, <span>koike-haruki@med.nagoya-u.ac.jp</span></p>
</div>
<div class="fn" id="c002">
<sup>*</sup><p class="display-inline">Sung-Tsang Hsieh, <span>shsieh@ntu.edu.tw</span></p>
</div>
<div class="fn" id="fn004"><p>This article was submitted to Neurocognitive aging and behavior, a section of the journal Frontiers in Aging Neuroscience</p></div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2021 Sep 30; Accepted 2021 Nov 29; Collection date 2021.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright © 2022 Hsueh, Chao, Chang, Jeng, Katsuno, Koike and Hsieh.</div>
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC8826435  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35153720/" class="usa-link">35153720</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Objective</h3>
<p>Hereditary transthyretin amyloidosis (ATTRv) encompasses different phenotypes among various genotypes. The analysis of the natural history and risk factors of faster progression in different genotypes would refine the treatment strategy.</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods</h3>
<p>The clinical manifestations of ATTRv from A97S (p.A117S) of Taiwanese and late-onset V30M (p.V50M) of Japanese were compared. An autopsy study of A97S was performed.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3>
<p>There existed three unique features in the A97S cohort compared to the V30M cohort: (1) dysphagia, (2) carpal tunnel syndrome (CTS), and (3) onset age. First, dysphagia was common in A97S (53.4%) but not in V30M and served as a contributor to fast disease progression. All phases of swallowing were affected. In the autopsy pathology, there were extensive amyloid deposits in the viscera and nerves of the tongue, larynx, and esophagus. In A97S, 45 patients (43.3%) had a history of CTS before the onset of length-dependent symptoms by 3 years. The amyloid deposition was more prominent in the median nerve than that in the transverse carpal ligament. The onset age at different stages was younger in the A97S cohort than the V30M cohort by 4–5 years.</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusion</h3>
<p>These phenotypic characteristics together with autopsy pathology in A97S are distinct from V30M. Early dysphagia in A97S correlated with fast progression. In A97S, median neuropathy leading to CTS might be in a continuous spectrum of ATTRv course rather than an independent disease entity. Such observations may serve as a foundation to explore and analyze unique phenotypes among various genotypes.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> hereditary transthyretin amyloidosis (ATTRv), carpal tunnel syndrome, dysphagia, amyloid deposition, natural course</p></section></section><section id="S1"><h2 class="pmc_sec_title">Introduction</h2>
<p>Various mutations of hereditary transthyretin amyloidosis (ATTRv) or familial amyloid polyneuropathy (FAP), which affects motor, sensory, and autonomic nerves, encompass different phenotypes (<a href="#B5" class="usa-link" aria-describedby="B5">Ando et al., 2013</a>; <a href="#B11" class="usa-link" aria-describedby="B11">Carr et al., 2016</a>; <a href="#B43" class="usa-link" aria-describedby="B43">Sridharan et al., 2018</a>; <a href="#B3" class="usa-link" aria-describedby="B3">Adams et al., 2019</a>; <a href="#B18" class="usa-link" aria-describedby="B18">Damy et al., 2019</a>; <a href="#B19" class="usa-link" aria-describedby="B19">Dang et al., 2019</a>; <a href="#B32" class="usa-link" aria-describedby="B32">Lane et al., 2019</a>). While the V30M (p.V50M) (<a href="#B6" class="usa-link" aria-describedby="B6">Benson et al., 2020</a>) with polyneuropathy is the most common pathogenic variant in Japan and around the world (<a href="#B27" class="usa-link" aria-describedby="B27">Ikeda et al., 2002</a>; <a href="#B1" class="usa-link" aria-describedby="B1">Adams et al., 2015</a>; <a href="#B16" class="usa-link" aria-describedby="B16">Coelho et al., 2018</a>; <a href="#B45" class="usa-link" aria-describedby="B45">Yamashita et al., 2019</a>), A97S (p.A117S) (<a href="#B6" class="usa-link" aria-describedby="B6">Benson et al., 2020</a>) constitutes the most frequent mutation in Taiwan and has been reported in China (<a href="#B21" class="usa-link" aria-describedby="B21">Du et al., 2021</a>), Malaysia (<a href="#B33" class="usa-link" aria-describedby="B33">Low et al., 2019</a>), and Thailand (<a href="#B39" class="usa-link" aria-describedby="B39">Pasutharnchat et al., 2021</a>). V30M in Japan had two onset patterns, namely, early- vs. late-onset type (<a href="#B29" class="usa-link" aria-describedby="B29">Koike et al., 2002</a>, <a href="#B30" class="usa-link" aria-describedby="B30">2004</a>, <a href="#B31" class="usa-link" aria-describedby="B31">2012</a>), and the latter was also reported in Portugal and France (<a href="#B17" class="usa-link" aria-describedby="B17">Conceição and De Carvalho, 2007</a>; <a href="#B20" class="usa-link" aria-describedby="B20">Dohrn et al., 2013</a>; <a href="#B10" class="usa-link" aria-describedby="B10">Buades-Reinés et al., 2016</a>; <a href="#B40" class="usa-link" aria-describedby="B40">Pinto et al., 2019</a>). In contrast, the onset age of A97S in Taiwan was generally after the 5th decade (<a href="#B13" class="usa-link" aria-describedby="B13">Chao et al., 2019</a>). Under the umbrella of the late-onset ATTRv, it is unknown which features were different between A97S and V30M. Furthermore, given the development of new disease-modifying therapies, it is crucial to identify risk factors for symptomatic ATTRv at the early stage of the disease to initiate treatments (<a href="#B12" class="usa-link" aria-describedby="B12">Castaño et al., 2012</a>; <a href="#B8" class="usa-link" aria-describedby="B8">Berk et al., 2013</a>; <a href="#B2" class="usa-link" aria-describedby="B2">Adams et al., 2018</a>, <a href="#B3" class="usa-link" aria-describedby="B3">2019</a>; <a href="#B7" class="usa-link" aria-describedby="B7">Benson et al., 2018</a>; <a href="#B35" class="usa-link" aria-describedby="B35">Maurer et al., 2018</a>; <a href="#B25" class="usa-link" aria-describedby="B25">Groothof et al., 2020</a>). Thus, it is important to analyze the natural history of the disease and, in particular, risk factors for early-onset and accelerating progression by the same measurements among different genotypes.</p>
<p>In ATTRv, there are certain manifestations, serving as prodrome symptoms, but there were not examined extensively and even correlated with autopsy pathology, such as dysphagia and carpal tunnel syndrome (CTS). Dysphagia is an intriguing symptom of ATTRv, and amyloid deposits in lower cranial nerves were reported as the possible cause (<a href="#B26" class="usa-link" aria-describedby="B26">Ikeda et al., 1998</a>; <a href="#B38" class="usa-link" aria-describedby="B38">Obici and Suhr, 2019</a>). However, the frequency of dysphagia in different genotypes remains elusive. An integrated study incorporating clinical profiles, functional study of swallowing, and pathology is needed to clarify (1) the underlying pathophysiology and (2) its effect on the natural course of ATTRv.</p>
<p>Traditionally, CTS in ATTRv is considered as an entrapment neuropathy of the median nerve by the compression of the surrounding tissue, and amyloid was detected in the transverse carpal ligament (<a href="#B41" class="usa-link" aria-describedby="B41">Samões et al., 2017</a>). However, the amyloid deposition of the wild-type TTR was also reported in the transverse carpal ligament of patients with idiopathic CTS (<a href="#B23" class="usa-link" aria-describedby="B23">Gioeva et al., 2013</a>). Furthermore, the response to carpal tunnel release surgery in CTS of ATTRv was impersistent (<a href="#B5" class="usa-link" aria-describedby="B5">Ando et al., 2013</a>). All these observations prompted us to examine: (1) the mechanisms of CTS in ATTRv and (2) the clinical significance of CTS in ATTRv, i.e., whether it reflects a state or disease progression.</p>
<p>To address the above issues, this study analyzed the clinical profiles and laboratory tests of the two cohorts: A97S of Taiwanese and the late-onset V30M of Japanese to investigate the similarities and differences between these two cohorts. Furthermore, an autopsy case of A97S provided pathology underlying the mechanisms of the unique symptomatology of dysphagia and CTS.</p></section><section id="S2"><h2 class="pmc_sec_title">Materials and Methods</h2>
<section id="S2.SS1"><h3 class="pmc_sec_title">Patient Recruitment</h3>
<p>We recruited patients with ATTRv referred to the Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan, and the Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan. The evaluation of V30M cases was performed before 2012, and the Taiwanese cases were recruited until July 2020. Part of the clinical features and their course in V30M patients has been reported elsewhere (<a href="#B31" class="usa-link" aria-describedby="B31">Koike et al., 2012</a>). All patients were confirmed with the genetic diagnosis of A97S (p.A117S according to the 2020 updated nomenclature recommendation) (<a href="#B6" class="usa-link" aria-describedby="B6">Benson et al., 2020</a>) in Taiwanese and V30M (p.V50M) in Japanese with an age of onset older than 50 years (late-onset V30M, abbreviated as V30M in the following description). This retrospective study was approved by the Ethics Committee of the National Taiwan University Hospital, Taipei, Taiwan (ID: 201404014RINB, 201908065RINA), and the Nagoya University Graduate School of Medicine, Nagoya, Japan (ID: 2014-0424). Informed consent was obtained from all patients participating in the study.</p></section><section id="S2.SS2"><h3 class="pmc_sec_title">Clinical Evaluations</h3>
<p>All patients had detailed evaluations such as history taking, neurological examinations, and laboratory tests. The laboratory tests included a nerve conduction study and a blood test. In addition, 84 A97S patients and 39 V30M patients had accepted the cerebrospinal fluid (CSF) analysis. The neuropathy manifestations included motor, sensory, and autonomic symptoms, but the symptoms related to common entrapment neuropathy other than CTS or radiculopathy were excluded. The upper limb onset was defined as the motor and sensory symptoms other than CTS occurring at the upper limbs, and the asymmetric onset was defined as the interval of neuropathy symptoms that happened from one side to bilateral sides was longer than 3 months. Relevant information included: (1) paternal or maternal inheritance, (2) negative (numbness) and positive (tingling, spontaneous pain, and allodynia) sensory symptoms, and (3) autonomic symptoms (gastrointestinal symptoms: constipation, diarrhea, or alternating constipation and diarrhea, urinary symptoms, orthostatic dizziness, and erectile dysfunction).</p>
<p>Functional disability was evaluated according to a FAP stage score of 0–4 modified from the Coutinho’s staging system (<a href="#B4" class="usa-link" aria-describedby="B4">Adams et al., 2016</a>): 0, normal; 1, having mild neuropathy symptoms such as motor, sensory, or autonomic, but with an independent ambulance; 2, having major motor disturbances and needing support to walk; 3, being confined to a wheelchair or bed; and 4, death. We collected the onset time of CTS and each FAP stage. However, some patients in the A97S cohort (39/105, 37.1%) would use diflunisal (<a href="#B12" class="usa-link" aria-describedby="B12">Castaño et al., 2012</a>; <a href="#B8" class="usa-link" aria-describedby="B8">Berk et al., 2013</a>), tafamidis (<a href="#B35" class="usa-link" aria-describedby="B35">Maurer et al., 2018</a>), or small interference RNA (<a href="#B2" class="usa-link" aria-describedby="B2">Adams et al., 2018</a>) after the medication was available or lose follow-up, so we right-censored the data at the time of (1) starting medication or (2) losing follow-up for more accurate analysis of the natural course.</p></section><section id="S2.SS3"><h3 class="pmc_sec_title">Cardiac Assessment</h3>
<p>Because the early cardiac symptoms may be subtle or non-specific, we collected the first objective evidence rather than self-reported first symptoms. The first objective evidence means (1) patient have no symptoms but was examined after ATTRv was diagnosed or (2) patients have the symptoms that the clinician considered to be related to the heart. We evaluated the heart involvement by cardiac sonography, ECG, and 24-h Holter monitor. The cardiac sonography measured the thickness of the interventricular septum and posterior wall. The thickness greater than or equal to 1.3 cm was defined as ventricular hypertrophy. The sparkling myocardium on cardiac sonography was diagnosed as scattered distinct hyperechoic signals in the myocardium. In the heart rhythm assessed by Holter monitor and ECG, the abnormality was considered if (1) more than 100 supraventricular or ventricular ectopy were recorded in 1 day, (2) long pause over 3 s, and (3) arrhythmia such as atrial fibrillation, atrioventricular conduction block, intraventricular conduction block, or pacemaker rhythm.</p></section><section id="S2.SS4"><h3 class="pmc_sec_title">Swallowing Studies in Patients With A97S Cohort</h3>
<p>The swallowing function was evaluated by several functional studies such as videofluoroscopic swallowing study, esophageal transit scintigraphy, and sialoscintigraphy. In the videofluoroscopic swallowing study, patients were asked to swallow different quantities of barium suspension (thin: water; thick: honey-thick; and paste: pudding thick). The fluoroscopy would record the time of oral transit, pharyngeal transit, and swallowing triggers. The presence of penetration or aspiration was also recorded. Abnormal hyoid bone elevation was defined as the elevation that was lower than the mandible angle. In the esophageal transit scintigraphy, patients were asked to swallow radiotracer (1 millicurie technetium-99m phytate in 15 ml of water) in upright and supine positions, respectively. The esophageal transit time longer than 15 s was considered abnormal. In the sialoscintigraphy, patients accepted intravenous injection of 10 millicurie technetium-99m sodium pertechnetate, and serial anterior images were acquired every 60 s for 30 min. The accumulation function of salivary glands was evaluated in the first 15 min. The patient accepted oral ascorbic acid 500 mg at the time of 15 min to evaluate the excretory function of salivary glands. The accumulation and discharge curves were recorded.</p></section><section id="S2.SS5"><h3 class="pmc_sec_title">Pathology Studies From an Autopsy Patient With A97S</h3>
<p>We performed an autopsy of a patient with ATTRv. All procedures were approved by the National Taiwan University Hospital Research Ethics Committee, and informed consent was obtained from the patient and next of kin for body donation. Fixed organ and nerve tissues were harvested. The histological examinations included: (1) routine H&amp;E staining on 4-μm paraffin-embedded sections and (2) Congo red staining on 10-μm paraffin-embedded sections.</p></section><section id="S2.SS6"><h3 class="pmc_sec_title">Electron Microscopy of Sural Nerve Biopsies</h3>
<p>The assessment of nerve pathology followed our established protocol (<a href="#B14" class="usa-link" aria-describedby="B14">Chiang et al., 2005</a>). The sural nerves were collected at the level of the trifurcation of the sciatic nerve and then fixed in 5% glutaraldehyde in 0.1 M phosphate buffer at 4°C overnight. The tissues were post-fixed in 2% osmic acid for 2 h at room temperature, dehydrated, and embedded in Epon 812 resin (Polysciences, Philadelphia, PA, United States). Ultrathin (70 nm) sections were cut on a Reichert Ultracut E (Leica, Wetzlar, Germany), stained with uranyl acetate and lead citrate, and observed under a transmission electron microscope (H7100, Hitachi, Tokyo, Japan).</p></section><section id="S2.SS7"><h3 class="pmc_sec_title">Statistical Analysis</h3>
<p>Continuous variables, expressed as means ± SDs, were compared using the <em>t</em>-test if they followed a normal distribution (by Shapiro–Wilk test). The non-parametric test was used if the variables did not follow the normal distribution. The chi-square test or Fisher’s exact test were used to compare the categorical data. We used univariate linear regression and ANOVA to examine the contribution of the clinical factors to the onset of FAP stage 1. The Kaplan–Meier survival analysis was used to present the survival curves. The Cox proportional hazard model was used to evaluate the association of progression rate with baseline characteristics and clinical variables with “entering the next stage” as an event. Outliers were considered when the value is larger than the third quantile plus 1.5*interquartile range (IQR) or smaller than the first quantile minus 1.5*IQR. All analyses were performed using Stata software (StataCorp LP, College Station, TX, United States). The results were considered significant at a value of <em>P</em> &lt; 0.05.</p></section></section><section id="S3"><h2 class="pmc_sec_title">Results</h2>
<section id="S3.SS1"><h3 class="pmc_sec_title">Unique Manifestations: A97S vs. V30M</h3>
<p>This study recruited subjects with confirmed TTR genotypes: A97S (105 Taiwanese patients) and late-onset V30M (50 Japanese patients) with the age of onset (entering FAP stage 1) ≥ 50 years. The clinical phenotypes and laboratory findings are summarized in <a href="#T1" class="usa-link">Tables 1</a>, <a href="#T2" class="usa-link">2</a> and <a href="#TS1" class="usa-link">Supplementary Table 1</a>. There were two unique features in the A97S cohort, namely, dysphagia and CTS.</p>
<section class="tw xbox font-sm" id="T1"><h4 class="obj_head">TABLE 1.</h4>
<div class="caption p"><p>Clinical profiles in hereditary transthyretin amyloidosis.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups" cellspacing="5" cellpadding="5">
<thead><tr>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">A97S of Taiwan (<em>N</em> = 105) <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">V30M of Japan (<em>N</em> = 50) <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">
<em>P</em>
</td>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Male</td>
<td valign="top" align="center" rowspan="1" colspan="1">78/105 (74.3%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">43/50 (86%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.099</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Presence of dysphagia</td>
<td valign="top" align="center" rowspan="1" colspan="1">55/103 (53.4%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1/50 (2%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001<a href="#t1fns1" class="usa-link"><sup>*</sup></a>
</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Upper limb onset excluding CTS</td>
<td valign="top" align="center" rowspan="1" colspan="1">27/105 (25.7%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">5/50 (10.0%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.024<a href="#t1fns1" class="usa-link"><sup>*</sup></a>
</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Initial symptom of amyloidosis</strong>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Autonomic</td>
<td valign="top" align="center" rowspan="1" colspan="1">17/105 (16.2%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">5/50 (10.0%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.302</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Sensory</td>
<td valign="top" align="center" rowspan="1" colspan="1">65/105 (61.9%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">33/50 (66.0%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.621</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Motor</td>
<td valign="top" align="center" rowspan="1" colspan="1">7/105 (6.7%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">3/50 (6.0%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.875</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Motor and sensory</td>
<td valign="top" align="center" rowspan="1" colspan="1">13/105 (12.4%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">4 (8%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.415</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Heart</td>
<td valign="top" align="center" rowspan="1" colspan="1">3/105 (2.9%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2/50 (4.0%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.658</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Ocular</td>
<td valign="top" align="center" rowspan="1" colspan="1">0/105 (0%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">3/50 (6.0%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.032<a href="#t1fns1" class="usa-link"><sup>*</sup></a>
</td>
</tr>
<tr><td valign="top" align="left" colspan="4" rowspan="1">
<strong>Onset age of the symptoms</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">motor symptom</td>
<td valign="top" align="center" rowspan="1" colspan="1">62.2 ± 6 (<em>n</em> = 105)</td>
<td valign="top" align="center" rowspan="1" colspan="1">66.3 ± 6.2 (<em>n</em> = 42)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.0006<a href="#t1fns1" class="usa-link"><sup>*</sup></a>
</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">sensory symptom</td>
<td valign="top" align="center" rowspan="1" colspan="1">61.2 ± 6.3 (<em>n</em> = 102)</td>
<td valign="top" align="center" rowspan="1" colspan="1">65.0 ± 6.5 (<em>n</em> = 50)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.0008<a href="#t1fns1" class="usa-link"><sup>*</sup></a>
</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">autonomic symptom</td>
<td valign="top" align="center" rowspan="1" colspan="1">62.3 ± 6.8 (<em>n</em> = 103)</td>
<td valign="top" align="center" rowspan="1" colspan="1">66.4 ± 6.3 (<em>n</em> = 43)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.0021<a href="#t1fns1" class="usa-link"><sup>*</sup></a>
</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">heart with laboratory evidence</td>
<td valign="top" align="center" rowspan="1" colspan="1">64.2 ± 6.3 (<em>n</em> = 89)</td>
<td valign="top" align="center" rowspan="1" colspan="1">69.3 ± 6.2 (<em>n</em> = 23)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.0006<a href="#t1fns1" class="usa-link"><sup>*</sup></a>
</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Sensory symptom</strong>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Numbness</td>
<td valign="top" align="center" rowspan="1" colspan="1">105/105 (100%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">50/50 (100%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">-</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Spontaneous pain</td>
<td valign="top" align="center" rowspan="1" colspan="1">75/103 (73.5%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">34/50 (68.0%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.477</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Autonomic symptoms</strong>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Gastrointestinal symptom</td>
<td valign="top" align="center" rowspan="1" colspan="1">89/105 (84.8%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">40/50 (80.0%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.458</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Urinary symptoms</td>
<td valign="top" align="center" rowspan="1" colspan="1">45/105 (42.9%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">24/50 (48.0%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.547</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Orthostatic dizziness</td>
<td valign="top" align="center" rowspan="1" colspan="1">69/105 (66.3%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">27/50 (54.0%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.139</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Erectile dysfunction</td>
<td valign="top" align="center" rowspan="1" colspan="1">40/78 (51.3%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">10/21 (47.6%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.846-</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Death etiology</strong>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Heart failure</td>
<td valign="top" align="center" rowspan="1" colspan="1">23/47 (48.9%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">8/21 (38.0%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.407</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Cachexia with secondary infection</td>
<td valign="top" align="center" rowspan="1" colspan="1">9/47 (19.1%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">4/21 (19.0%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.000</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Sudden death</td>
<td valign="top" align="center" rowspan="1" colspan="1">7/47 (14.9%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">7/21 (33.3%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.082</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="fn4"><p>
<em>CTS, Carpal tunnel syndrome.</em>
</p></div>
<div class="fn" id="fn5"><p>
<em>The history of CTS was defined according to the following two criteria: (1) The patient had been diagnosed and treated by a specialist and (2) The symptom improved after treatment such as rehabilitation and surgery.</em>
</p></div>
<div class="fn" id="t1fns1"><p>
<em>*P &lt; 0.05.</em>
</p></div>
</div></section><section class="tw xbox font-sm" id="T2"><h4 class="obj_head">TABLE 2.</h4>
<div class="caption p"><p>Laboratory findings at diagnosis.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups" cellspacing="5" cellpadding="5">
<thead><tr>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">A97S of Taiwan (<em>N</em> = 105) <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">V30M of Japan (<em>N</em> = 50) <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">
<em>P</em>
</td>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Sonography of heart evaluation</strong>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Ventricular hypertrophy</td>
<td valign="top" align="center" rowspan="1" colspan="1">74/94 (82.2%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">18/27 (66.7%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.196</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Sparkling pattern</td>
<td valign="top" align="center" rowspan="1" colspan="1">37/92 (42%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">12/24 (50%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.388</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Cardiac rhythm</strong>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">–</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Frequent supraventricular or ventricular ectopy<a href="#t2fna" class="usa-link"><sup>a</sup></a>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">41/80 (51.3%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0/5 (0%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.056</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Long pause &gt; 3 s</td>
<td valign="top" align="center" rowspan="1" colspan="1">1/80 (1.3%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0/5 (0%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.000</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Arrhythmia<a href="#t2fns1" class="usa-link"><sup>*</sup></a>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">42/80 (52.5%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">5/6 (83.3%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.215</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Any abnormality</td>
<td valign="top" align="center" rowspan="1" colspan="1">65/80 (81.3%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">5/8 (62.5%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.155</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Pacemaker implantation</td>
<td valign="top" align="center" rowspan="1" colspan="1">11/105 (10.5%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">7/50 (14%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.522</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Cerebrospinal fluid protein (mg/dL)</td>
<td valign="top" align="center" rowspan="1" colspan="1">64.9 ± 28.8</td>
<td valign="top" align="center" rowspan="1" colspan="1">56.2 ± 29.8</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.024</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Serum Creatine &gt; 1.5 mg/dL</td>
<td valign="top" align="center" rowspan="1" colspan="1">2/98 (2%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0/36 (0%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.000</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Nerve conduction studies</strong>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Median nerve</strong>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Mean MCV (m/s)</td>
<td valign="top" align="center" rowspan="1" colspan="1">43.4 ± 6.8</td>
<td valign="top" align="center" rowspan="1" colspan="1">45.2 ± 9.8</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.164</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Mean DL (m/s)</td>
<td valign="top" align="center" rowspan="1" colspan="1">6.2 ± 1.3</td>
<td valign="top" align="center" rowspan="1" colspan="1">5.3 ± 1.7</td>
<td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001<a href="#t2fnh" class="usa-link"><sup>#</sup></a>
</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Mean CMAP (m/s)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.5 ± 2</td>
<td valign="top" align="center" rowspan="1" colspan="1">3.3 ± 2.8</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.032<a href="#t2fnh" class="usa-link"><sup>#</sup></a>
</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Mean SCV (m/s)</td>
<td valign="top" align="center" rowspan="1" colspan="1">40.8 ± 8.7</td>
<td valign="top" align="center" rowspan="1" colspan="1">46.6 ± 5.8</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.863</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Mean SNAP (uV)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.8 ± 4.7</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.3 ± 3.6</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.006<a href="#t2fnh" class="usa-link"><sup>#</sup></a>
</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Mean Terminal latency index</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.32 ± 0.06</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.37 ± 0.1</td>
<td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001<a href="#t2fnh" class="usa-link"><sup>#</sup></a>
</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Terminal latency index &lt; 0.35</td>
<td valign="top" align="center" rowspan="1" colspan="1">53/73 (72.6%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">17/45 (37.8%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001<a href="#t2fnh" class="usa-link"><sup>#</sup></a>
</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Tibial nerve</strong>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">MCV (m/s)</td>
<td valign="top" align="center" rowspan="1" colspan="1">36.3 ± 6.2</td>
<td valign="top" align="center" rowspan="1" colspan="1">37.1 ± 5.6</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.506</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">DL (m/s)</td>
<td valign="top" align="center" rowspan="1" colspan="1">5 ± 1.9</td>
<td valign="top" align="center" rowspan="1" colspan="1">5.8 ± 1.4</td>
<td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001<a href="#t2fnh" class="usa-link"><sup>#</sup></a>
</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">CMAP (m/s)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.5 ± 2.4</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.5 ± 0.9</td>
<td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001<a href="#t2fnh" class="usa-link"><sup>#</sup></a>
</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Sural nerve</strong>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">SCV (m/s)</td>
<td valign="top" align="center" rowspan="1" colspan="1">44 ± 6.1</td>
<td valign="top" align="center" rowspan="1" colspan="1">38.1 ± 5.2</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.595</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">SNAP (m/s)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.1 ± 3.2</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.6 ± 1.6</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.012<a href="#t2fnh" class="usa-link"><sup>#</sup></a>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="t2fna"><p>
<em><sup>a</sup>Over 100 supraventricular or ventricular ectopy in one day.</em>
</p></div>
<div class="fn" id="t2fns1"><p>
<em>* Arrhythmia such as atrial fibrillation, atrioventricular conduction block, or intraventricular conduction block. MCV, motor conduction velocity; DL, distal latency; CMAP, compound motor action potential; SCV, sensory conduction velocity; SNAP, sensory nerve action potential.</em>
</p></div>
<div class="fn" id="t2fnh"><p>
<em><sup>#</sup> P &lt; 0.05.</em>
</p></div>
</div></section></section><section id="S3.SS2"><h3 class="pmc_sec_title">Dysphagia in A97S</h3>
<p>Dysphagia was a distinct symptom in A97S compared to V30M (53.4 vs. 2.0%, <em>P</em> &lt; 0.001). Associated symptoms in A97S included choking (43.6%) and hoarseness (31.7%). Aspiration pneumonia was noted in 19.4% of the A97S patients. Among the 56 A97S patients entering FAP stage 1, 22 patients had dysphagia, choking, or hoarseness before the diagnosis. Fourteen patients had completed examinations for dysphagia (<a href="#T3" class="usa-link">Table 3</a>). There was no structural lesion grossly in these patients. The videofluoroscopic swallowing study revealed oropharyngeal dysphagia in these patients. The transit times of the oral phase and pharyngeal phase were all prolonged when the patients swallowed liquids with various contents, but the swallowing trigger time was not prolonged. The penetration or aspiration was also noted, and the level of hyoid bone elevation during swallowing was lower than that of the mandible angle. The transit time of the esophageal phase was prolonged in all patients in the supine position but was prolonged in only one patient in the upright position. Notably, the non-peristaltic contraction was noted in 2 patients. The sialoscintigraphy revealed accumulation or excretion dysfunction in salivary glands. These functional studies were complementary to dysphagia symptoms that developed at the early stage of A97S. We also compared the laboratory findings between the patients of ATTRA97S entering FAP stage 1 with dysphagia and those without dysphagia (<a href="#TS1" class="usa-link">Supplementary Table 2</a>). Notably, the mean of terminal latency index, abnormal terminal latency index rate, and the sural sensory nerve action potential were worse in the patients without dysphagia.</p>
<section class="tw xbox font-sm" id="T3"><h4 class="obj_head">TABLE 3.</h4>
<div class="caption p"><p>Examinations of dysphagia in the A97S cohort.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups" cellspacing="5" cellpadding="5">
<thead><tr>
<td valign="top" align="left" rowspan="1" colspan="1">Examinations</td>
<td valign="top" align="center" rowspan="1" colspan="1">Median (range)</td>
<td valign="top" align="center" rowspan="1" colspan="1">Abnormal rate</td>
<td valign="top" align="center" rowspan="1" colspan="1">Norm</td>
</tr></thead>
<tbody>
<tr><td valign="top" align="left" colspan="4" rowspan="1">
<strong>Video fluoroscopic swallowing study (<em>n</em> = 8)</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Oral transit time (thin)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.91 (0.5–45.38)</td>
<td valign="top" align="center" rowspan="1" colspan="1">4 (50%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">&lt;2 s</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Oral transit time (thick)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.85 (0.44–10.41)</td>
<td valign="top" align="center" rowspan="1" colspan="1">4 (50%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">&lt;2 s</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Oral transit time (paste)</td>
<td valign="top" align="center" rowspan="1" colspan="1">3.65 (0.63–27.87)</td>
<td valign="top" align="center" rowspan="1" colspan="1">6 (75%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">&lt;2 s</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Pharyngeal transit time (thin)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.62 (1.16–2.62)</td>
<td valign="top" align="center" rowspan="1" colspan="1">8 (100%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">&lt;1 s</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Pharyngeal transit time (thick)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.29 (0.9–3.13)</td>
<td valign="top" align="center" rowspan="1" colspan="1">7 (87.5%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">&lt;1 s</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Pharyngeal transit time (paste)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.33 (1.15–5.97)</td>
<td valign="top" align="center" rowspan="1" colspan="1">7 (100%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">&lt;1 s</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Swallowing triggers (thin)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.285 (0.17–1.85)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2 (25%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">&lt;1 s</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Swallowing triggers (thick)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.18 (0.13–0.54)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">&lt;1 s</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Swallowing triggers (paste)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.26 (0.1–4.71)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (12.5%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">&lt;1 s</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Penetration or aspiration</td>
<td rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">3 (37.5%)</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Abnormal hyoid bone elevation<a href="#t3fns1" class="usa-link"><sup>*</sup></a>
</td>
<td rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">2 (25%)</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr><td valign="top" align="left" colspan="4" rowspan="1">
<strong>Esophageal transit time (ETT) (<em>n</em> = 4)</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Prolonged ETT in upright position</td>
<td rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (25%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">&lt;15 s</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Prolonged ETT in supine position</td>
<td rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">4 (100%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">&lt;15 s</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Non-peristaltic contractions</td>
<td rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">2 (50%)</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Sialoscintigraphy (<em>n</em> = 5)</strong>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Excretory dysfunction</td>
<td rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">2 (40%)</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Accumulation dysfunction</td>
<td rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">3 (60%)</td>
<td rowspan="1" colspan="1"></td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="t3fns1"><p>
<em>*Abnormal hyoid bone elevation is defined as the elevation that was lower than the mandible angle.</em>
</p></div></div></section><p>We further investigated the underlying pathology in an autopsy case of A97S. There were marked amyloid deposits in the tongue, larynx, and esophagus and submucosal nerve fibers (<a href="#F1" class="usa-link">Figures 1A–C</a>), providing microscopical evidence as to the mechanisms of amyloid pathology in the swallowing structures and innervation during the oral phase, pharyngeal phase, and esophageal phase.</p>
<figure class="fig xbox font-sm" id="F1"><h4 class="obj_head">FIGURE 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8826435_fnagi-13-786322-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/537b/8826435/a44e97c1c16a/fnagi-13-786322-g001.jpg" loading="lazy" height="884" width="700" alt="FIGURE 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/F1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Amyloid pathology of the median nerve and visceral organs from an autopsy of A97S patient. Amyloid deposits were demonstrated in the tongue <strong>(A)</strong>, laryngeal wall <strong>(B)</strong>, and upper esophageal wall <strong>(C)</strong> including in the submucosal nerve fibers (<strong>C</strong>, inset). Amyloid deposits were also abundant in the endoneurium and perineurium of the median nerve at the level of carpal tunnel (<strong>D</strong>, inset). In contrast, the amyloid deposition was much less in the transverse carpal ligament <strong>(E)</strong>. Arrow: amyloid deposits in the endoneurium; Arrowhead: amyloid deposits in the perineurium; asterisk: amyloid deposits in the vascular wall. First column: H&amp;E staining; Second column: Congo red staining under a regular light microscope; Third column: Congo red staining under a polarized microscope. Scale bars = 50 μm.</p></figcaption></figure></section><section id="S3.SS3"><h3 class="pmc_sec_title">Carpal Tunnel Syndrome in A97S</h3>
<p>In the A97S cohort, CTS was a unique feature compared to the V30M cohort: 43.3% had CTS confirmed by a neurologist according to nerve conduction studies or a history of carpal tunnel release surgery. The onset age of symptomatic CTS was younger than the length-dependent symptoms (57.6 ± 6.3 vs. 60.6 ± 6.3, <em>P</em> = 0.004) in the A97S cohort. Despite the operations, most symptoms were only mildly and transiently alleviated. The diagnosis of CTS was further validated by neurophysiological evidence of reduced terminal latency index in A97S compared to that in V30M (0.32 ± 0.06 vs. 0.37 ± 0.10, <em>P</em> &lt; 0.001). A terminal latency index smaller than 0.35 served as a criterion to diagnose CTS (<a href="#B22" class="usa-link" aria-describedby="B22">Dumitru et al., 2002</a>). The phenomenon of more frequent CTS in A97S was further substantiated by a higher proportion of A97S with abnormal terminal latency index than V30M (72.6 vs. 37.8%, <em>P</em> &lt; 0.001, <a href="#T2" class="usa-link">Table 2</a>). Such an observation corroborated with our report of the median nerve neuropathy as an early manifestation of A97S (<a href="#B15" class="usa-link" aria-describedby="B15">Chiang et al., 2021</a>). Furthermore, we had the opportunity to examine an autopsy of an A97S patient. The pathology showed much amyloid deposition in the endoneurial area of the median nerve at the level of carpal tunnel in comparison with the relatively scant amount of amyloids in the transverse carpal ligament (<a href="#F1" class="usa-link">Figures 1D,E</a>), providing evidence of amyloid pathology in the median nerve and contributing to the development of CTS.</p></section><section id="S3.SS4"><h3 class="pmc_sec_title">Phenotypic Characterization of A97S vs. V30M: Distinct and Shared Features in Amyloid Fibril Ultrastructure and Progression</h3>
<p>The different genotypes of A97S vs. V30M yielded distinct amyloid patterns in nerve biopsies observed under electron microscopy (<a href="#F2" class="usa-link">Figure 2</a>). Amyloid fibrils were generally short and thin in the A97S (<em>n</em> = 20) and late-onset V30M patients (<em>n</em> = 32). These patterns were in contrast to that of the early-onset V30M (<em>n</em> = 6), which tended to be long.</p>
<figure class="fig xbox font-sm" id="F2"><h4 class="obj_head">FIGURE 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8826435_fnagi-13-786322-g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/537b/8826435/ded91aa1aa86/fnagi-13-786322-g002.jpg" loading="lazy" height="660" width="660" alt="FIGURE 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/F2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Electron microscopic findings of amyloid fibrils in the endoneurium. Cross-sections of sural nerve biopsy specimens from patients with hereditary transthyretin amyloidosis (ATTRv). <strong>(A,B)</strong> A97S patients from Taiwan, <strong>(C)</strong> Late-onset V30M patient from a non-endemic area of Japan, and <strong>(D)</strong> Early-onset V30M patient from an endemic focus of Japan. A microvessel indicated by an arrow is apposed by a mass of amyloid fibrils (asterisk) <strong>(A)</strong>. Amyloid fibrils are generally short and thin in the A97S and late-onset V30M patients <strong>(B,C)</strong>, while they tend to be long in the early-onset V30M patient <strong>(D)</strong>. Uranyl acetate and lead citrate stain. Scale bars = 5 μm <strong>(A)</strong> and 0.2 μm <strong>(B–D)</strong>.</p></figcaption></figure><p>The distribution of patients at different stages was similar (<em>P</em> = 0.13) at the time of the first referral to our medical centers. In the A97S cohort, there were 49 patients entering FAP stage 3, 22 patients stayed in FAP stage 2, and 34 patients stayed in FAP stage 1. In the V30M group, 31 patients entered FAP stage 3, 5 patients stayed in FAP stage 2, and 14 patients stayed in FAP stage 1. The backgrounds and clinical characteristics are listed in <a href="#T1" class="usa-link">Tables 1</a>, <a href="#T2" class="usa-link">2</a>. Among the patients with sudden death in both cohorts, only one patient in the A97S cohort had pacemaker implantation. In summary, there were more patients with neuropathic symptoms starting from upper limbs (excluding CTS) in A97S patients than late-onset V30M patients (25.7 vs. 10.0%, <em>P</em> = 0.024), and other clinical manifestations were similar between these two cohorts. Three patients in the V30M cohort had ocular symptoms as the onset symptom, but this was not observed in the A97S cohort. All three Japanese patients with ocular symptoms accepted operation for vitreous opacities, and amyloid deposits were detected in one patient.</p></section><section id="S3.SS5"><h3 class="pmc_sec_title">Natural Course of Hereditary Transthyretin Amyloidosis Between A97S and V30M: Onset and Progression</h3>
<p>The onset age was different between A97S and V30M, i.e., the age of onset and the age of entering FAP stage 2 and FAP stage 3 were younger in A97S patients than in V30M patients (<a href="#F3" class="usa-link">Figure 3</a>), but the interval from FAP stage 1 to 2, 2 to 3, and 1 to 3 was similar between these two cohorts (<a href="#F4" class="usa-link">Figures 4A–C</a>). We further analyzed the interval of FAP 1–2 and 2–3 in patients who had entered into FAP stage 3. The disability became accelerating when entering into FAP stage 2, i.e., the interval of FAP 2–3 was shorter than that of FAP 1–2 in both cohorts (A97S: 3.0 ± 2.0 years vs. 1.4 ± 1.0 years, <em>P</em> &lt; 0.0001; V30M: 2.7 ± 2.7 years vs. 1.4 ± 0.8 years, <em>P</em> = 0.04) (<a href="#F4" class="usa-link">Figure 4D</a>).</p>
<figure class="fig xbox font-sm" id="F3"><h4 class="obj_head">FIGURE 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8826435_fnagi-13-786322-g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/537b/8826435/4afd668a1652/fnagi-13-786322-g003.jpg" loading="lazy" height="449" width="708" alt="FIGURE 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/F3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The natural course of ATTRv of A97S and V30M: comparing the histogram of the age in each familial amyloid polyneuropathy (FAP) stage. The histograms of the age for each FAP stage are depicted between A97S Taiwanese vs. V30M Japanese patients <strong>(A–D)</strong>. At all stages, the A97S cohort had earlier onset age, i.e., entering FAP stage 1 <strong>(A)</strong>, and the age entering successive FAP stage <strong>(B–D)</strong>.</p></figcaption></figure><figure class="fig xbox font-sm" id="F4"><h4 class="obj_head">FIGURE 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8826435_fnagi-13-786322-g004.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/537b/8826435/04ff3ab906bc/fnagi-13-786322-g004.jpg" loading="lazy" height="447" width="708" alt="FIGURE 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/F4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The disease progression in ATTRv between A97S and V30M according to the interval of FAP stage from 1 to 2, 2 to 3, and 1 to 3. There was no difference in the Kaplan–Meier survival curve between A97S and V30M according to the analysis of the interval entering stage 2 from stage 1 <strong>(A)</strong>, in the interval entering stage 3 from stage 2 <strong>(B)</strong>, and in the interval entering stage 3 from stage 1 <strong>(C)</strong>. <strong>(D)</strong> The interval of FAP stage 1–2 was longer than the interval of FAP stage 2–3 in both A97S and V30M ATTRv cohorts (A97S: 3.0 ± 2.0 years vs. 1.4 ± 1.0 years, <em>P</em> &lt; 0.0001; V30M: 2.7 ± 2.7 years vs. 1.4 ± 0.8 years, <em>P</em> = 0.04). *<em>P</em> &lt; 0.05; **<em>P</em> &lt; 0.01; ns, no significant differences.</p></figcaption></figure></section><section id="S3.SS6"><h3 class="pmc_sec_title">Factors Affecting the Onset Age of Hereditary Transthyretin Amyloidosis</h3>
<p>We then explored the factors affecting the onset age of ATTRv with linear regression and ANOVA. The univariate analysis showed that the male sex was related to the earlier onset in A97S patients but such a difference did not exist in the late-onset V30M patients [β coefficient (95% CI): A97S: -4.8 (-7.5 to -2.2) vs. V30M: -0.37 (-5.78 to 5.04)]. In contrast, there was no effect on the onset age from whether the upper limb onset neuropathic symptoms [β coefficient (95% CI): A97S: -2.3 (-5 to 0.47) vs. V30M: 0.9 (-4.87 to 6.67)] or paternal inheritance [β coefficient (95% CI): A97S: 2.3 (-1.7 to 6.3) vs. V30M: -5.43 (-14.3 to 3.49)]. The ANOVA analysis revealed no significant effect on the onset age in the respect of initial symptoms of ATTRv in both cohorts.</p></section><section id="S3.SS7"><h3 class="pmc_sec_title">Factors Affecting the Progression of Hereditary Transthyretin Amyloidosis</h3>
<p>To understand the clinical factors contributing to disease progression, we analyzed patients who had been evaluated at FAP stage 1 and 2 with the Cox hazard model after excluding the outliers (51 A97S patients and 26 V30M patients who had been evaluated at FAP stage 1, and 34 A97S patients and 8 V30M patients who had been evaluated at stage 2). These factors affecting the progression rate of ATTRv are summarized in <a href="#T4" class="usa-link">Table 4</a>. In the univariate analysis of A97S patients, the early presence of dysphagia was related to a faster progression rate from stage 1 to 2. However, these risk factors in the A97S cohort were not noted in the V30M cohort.</p>
<section class="tw xbox font-sm" id="T4"><h4 class="obj_head">TABLE 4.</h4>
<div class="caption p"><p>Clinical factors affecting the progression in ATTRv.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups" cellspacing="5" cellpadding="5">
<thead>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="center" colspan="2" rowspan="1">ATTRA97S in Taiwan<hr>
</td>
<td valign="top" align="center" colspan="2" rowspan="1">ATTRV30M in Japan<hr>
</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Univariate Cox hazard model</td>
<td valign="top" align="center" rowspan="1" colspan="1">Stage 1 → 2 (<em>n</em> = 51)</td>
<td valign="top" align="center" rowspan="1" colspan="1">Stage 2 → 3 (<em>n</em> = 34)</td>
<td valign="top" align="center" rowspan="1" colspan="1">Stage 1 → 2 (<em>n</em> = 23)</td>
<td valign="top" align="center" rowspan="1" colspan="1">Stage 2 → 3 (<em>n</em> = 8)</td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Male sex</td>
<td valign="top" align="center" rowspan="1" colspan="1">5.93 (0.78–44.9)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.99 (0.21–4.74)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.35 (0.17–10.8)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.57 (0.18–14.1)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">ATTRv onset age</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.99 (0.91–1.07)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.95 (0.86–1.05)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.97 (0.87–1.09)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.05 (0.96–1.15)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Upper limb onset</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.67 (0.26–1.75)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.43 (0.44–4.58)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.11 (0.14–8.93)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.33 (0.12–14.7)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Paternal inheritance</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.40 (0.10–1.56)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.18 (0.02–2.05)</td>
<td valign="top" align="center" rowspan="1" colspan="1">-<a href="#t3fnsr" class="usa-link"><sup>#</sup></a>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">-<a href="#t3fnsr" class="usa-link"><sup>#</sup></a>
</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Weight loss</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.48 (0.61–3.58)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.00 (0.34–23.01)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.16 (0.34–4.04)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.09 (0.10–12.1)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Body mass index</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.90 (0.79–1.03)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.84 (0.63–1.12)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.84 (0.35–2.02)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.00 (0.45–2.21)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Dysphagia</td>
<td valign="top" align="center" rowspan="1" colspan="1">3.89 (1.61–9.40)<a href="#t3fnsg" class="usa-link"><sup>*</sup></a>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.02 (0.32–3.26)</td>
<td valign="top" align="center" rowspan="1" colspan="1">-<a href="#t3fnsr" class="usa-link"><sup>#</sup></a>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">-<a href="#t3fnsr" class="usa-link"><sup>#</sup></a>
</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">CSF protein (mg/dL)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.99 (0.97–1.01)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.01 (0.99–1.02)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.99 (0.97–1.02)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.00 (0.96–1.03)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">CSF protein (&gt;60 mg/dL)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.80 (0.33–1.95)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.46 (0.47–4.49)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.40 (0.25–7.82)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.15 (0.21–6.29)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="fn11"><p>
<em>Data expressed as hazard ratio (95% CI).</em>
</p></div>
<div class="fn" id="fn12"><p>
<em>CSF, cerebrospinal fluid; HR, hazard ratio.</em>
</p></div>
<div class="fn" id="t3fnsg"><p>
<em>*P &lt; 0.05.</em>
</p></div>
<div class="fn" id="t3fnsr"><p>
<em><sup>#</sup>No patients had the symptoms, or the patient number was insufficient to calculate the hazard ratio.</em>
</p></div>
</div></section></section></section><section id="S4"><h2 class="pmc_sec_title">Discussion</h2>
<p>This study demonstrated the unique clinical phenotypes between two genotypes of the A97S and the late-onset V30M, i.e., more frequent dysphagia, CTS, and earlier onset age in A97S. Furthermore, the distinct symptoms of dysphagia and CTS were evidenced by amyloid deposition in the visceral organs and nerves in the autopsy pathology. Such a combination of phenotype analysis and pathology examinations may serve as a foundation for future analysis in other genotypes. In addition to being a late-onset ATTRv, both cohorts shared similarities in (1) the majority of clinical symptoms and (2) the ultrastructure of the amyloid fibril, i.e., the length was comparable in A97S and late-onset V30M but shorter than the early-onset V30M Japanese cohort.</p>
<p>The A97S cohort had a unique symptom of dysphagia. Despite the report of this symptom (<a href="#B26" class="usa-link" aria-describedby="B26">Ikeda et al., 1998</a>; <a href="#B38" class="usa-link" aria-describedby="B38">Obici and Suhr, 2019</a>), dysphagia was not yet systemically examined in other genotypes (<a href="#B37" class="usa-link" aria-describedby="B37">Monteiro et al., 2012</a>). About half of the A97S patients had dysphagia, and dysphagia symptoms could be present at the early stage of ATTRv, which was rarely reported in other etiology of polyneuropathy. Furthermore, the presence of dysphagia at an early stage would suggest a faster progression in the A97S cohort. Swallowing could be divided into the oral phase, pharyngeal phase, and esophageal phase, and the videofluoroscopic swallowing study performed in part of ATTRA97S patients with dysphagia indicated that all these three phases were affected. Most patients mainly presented with dysphagia at the pharyngeal phase with choking. Previously, the cause of dysphagia was attributed to amyloid deposits in the hypoglossal nerve or vagus nerve (<a href="#B26" class="usa-link" aria-describedby="B26">Ikeda et al., 1998</a>; <a href="#B38" class="usa-link" aria-describedby="B38">Obici and Suhr, 2019</a>). Importantly, the A97S autopsy revealed extensive amyloid pathology in the tongue and larynx, providing pathological evidence that the structures governing swallowing were affected.</p>
<p>This study provided unique features and pathological data for CTS in A97S compared with the variable frequencies of CTS in different genotypes (<a href="#B34" class="usa-link" aria-describedby="B34">Mariani et al., 2015</a>; <a href="#B36" class="usa-link" aria-describedby="B36">Milandri et al., 2020</a>). Some patients had carpal tunnel release surgery, but the effect was minimal. This study provided the pathological evidence of amyloid deposits in the median nerve from an A97S autopsy, which likely contributed to the pathophysiology of CTS in A97S. Although amyloid that was deposited in the transverse carpal ligament was proposed as the cause of CTS in ATTRv (<a href="#B41" class="usa-link" aria-describedby="B41">Samões et al., 2017</a>), the minimal effect of carpal tunnel release surgery raised an alternative hypothesis. In A97S, the more prominent amyloid deposition in the median nerve than that in the transverse carpal ligament implied a direct effect of amyloid deposition on the median nerve serving as the pathogenesis of CTS. This amyloid pathology in the median nerve was different from the CTS in the general population or the compression hypothesis (<a href="#B41" class="usa-link" aria-describedby="B41">Samões et al., 2017</a>). Accordingly, the amyloid pathology in the median nerve at the wrist potentially prompted the median nerve vulnerable to the compression from surrounding tissue of the transverse carpal ligament (<a href="#B28" class="usa-link" aria-describedby="B28">Koike et al., 2011</a>). Such an observation also explains the observation of minimal or transient effect after release surgery (<a href="#B5" class="usa-link" aria-describedby="B5">Ando et al., 2013</a>). Furthermore, this study documented that the CTS onset was earlier than the onset of the length-dependent neuropathy symptoms. The observation may provide the explanation of our recent observation, i.e., the median neuropathy in the carriers of ATTRv was correlated with lower intraepidermal nerve fiber density and more abnormal electrophysiological parameters, and the median conduction parameters could serve as a surrogate marker of neuropathy involving both large- and small-fiber nerves in A97S carriers (<a href="#B15" class="usa-link" aria-describedby="B15">Chiang et al., 2021</a>). In summary, CTS in the A97S cohort may be in a continuous spectrum of ATTRv course rather than an independent disease entity.</p>
<p>Several unique features distinguished these two cohorts (A97S vs. V30M). Some Japanese patients had ocular symptoms while no Taiwanese patient had such a symptom. Dysphagia was present in half of the A97S cohort while no Japanese patients had dysphagia. The initial neuropathic symptoms in the upper limbs (excluding CTS) were more frequent in the A97S cohort than in the Japanese cohort (<a href="#B44" class="usa-link" aria-describedby="B44">Théaudin et al., 2019</a>). Furthermore, CTS appeared earlier than the length-dependent symptoms in A97S. The onset of clinical landmarks was generally earlier in the A97S cohort than the V30M cohort. In addition to genotype, these differences may imply the effect of ethnic or environmental contributions (<a href="#B29" class="usa-link" aria-describedby="B29">Koike et al., 2002</a>, <a href="#B30" class="usa-link" aria-describedby="B30">2004</a>). The male predominance was prominent in both cohorts. This observation may be related to earlier onset in male ATTRv, reported in Portugal (<a href="#B42" class="usa-link" aria-describedby="B42">Sousa et al., 1995</a>). Female siblings of the male patients were generally asymptomatic carriers in the Japanese late-onset V30M cohort. In a mouse model, 17β-estradiol and 5α-dihydrotestosterone upregulate transthyretin synthesis (<a href="#B24" class="usa-link" aria-describedby="B24">Gonçalves et al., 2008</a>).</p>
<p>Various disease-modifying therapies have been developed with convincing results in these years (<a href="#B12" class="usa-link" aria-describedby="B12">Castaño et al., 2012</a>; <a href="#B8" class="usa-link" aria-describedby="B8">Berk et al., 2013</a>; <a href="#B2" class="usa-link" aria-describedby="B2">Adams et al., 2018</a>; <a href="#B7" class="usa-link" aria-describedby="B7">Benson et al., 2018</a>; <a href="#B35" class="usa-link" aria-describedby="B35">Maurer et al., 2018</a>), and the timing to initiate the therapies becomes important and depends on the natural course study for different genotypes. Furthermore, the real world data after starting the disease-modify therapies should also be compared to the natural course to study the efficacy of different disease-modifying therapies. Our study clarified several risk factors for faster progression in the early stage (FAP stage 1–2) of the A97S cohort: the early presence of dysphagia. However, the correlation was not observed in the advanced stage (FAP stage 2–3). These findings may suggest the rapid acceleration of organ damage in patients without risk factors in the advanced stage. Further study is needed to observe whether the disease-modifying therapies would slow down the organ damage speed in the advanced stage of the patients without these risk factors and whether the disease-modifying therapies would reduce the effect of the risk factors.</p>
<p>Our study had several limitations. First, this study was a retrospective study incorporating two cohorts from two countries, and both recall bias and selection bias existed. Some patients (37.1% in the A97S cohort) received diflunisal (<a href="#B12" class="usa-link" aria-describedby="B12">Castaño et al., 2012</a>; <a href="#B8" class="usa-link" aria-describedby="B8">Berk et al., 2013</a>), tafamidis (<a href="#B35" class="usa-link" aria-describedby="B35">Maurer et al., 2018</a>), and patisiran (<a href="#B2" class="usa-link" aria-describedby="B2">Adams et al., 2018</a>), and we right-censored the data when these patients started these therapies. Thus, the effects of disease-modifying therapies on the natural course were not studied. Finally, the swallowing functional study was only performed in ATTRA97S patients with dysphagia. It is unclear whether the functional status was different between the patients with dysphagia and those without dysphagia. In a small ATTRV30M cohort, few patients without dysphagia also had esophageal dysfunction in esophageal manometry (<a href="#B9" class="usa-link" aria-describedby="B9">Bjerle et al., 1993</a>). Further study with detailed swallowing evaluation including symptoms and examinations in patients with ATTRv with different genotypes was needed.</p></section><section id="S5"><h2 class="pmc_sec_title">Conclusion</h2>
<p>This study demonstrates the similarity and difference in the phenotype of clinical manifestations between the two genotypes, namely, the A97S cohort and the late-onset V30M Japanese cohort. There are unique characteristics in the A97S cohort: (1) dysphagia at the early phase of ATTRv may be a risk factor of disease progression and (2) CTS potentially serves as a starting point in the continuous spectrum of amyloid neuropathy. The current approach of the phenotypical characterization with pathology examinations will serve as a foundation to analyze other genotypes for unique manifestations and underlying pathology and mechanisms. Given the development of disease-modifying therapies, these biomarkers may serve as an indicator for the early initiation of treatments.</p></section><section id="S6"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>The datasets generated during analysis and/or during the current study are available from the corresponding author on reasonable request.</p></section><section id="S7"><h2 class="pmc_sec_title">Ethics Statement</h2>
<p>The studies involving human participants were reviewed and approved by (1) Ethics Committee of the National Taiwan University Hospital, Taipei, Taiwan and (2) Ethics Committee of the Nagoya University Graduate School of Medicine, Nagoya, Japan. The patients/participants provided their written informed consent to participate in this study.</p></section><section id="S8"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>H-WH, HK, and S-TH wrote the manuscript with input from all authors. All authors contributed to data acquisition and analysis.</p></section><section id="conf1"><h2 class="pmc_sec_title">Conflict of Interest</h2>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></section><section id="pudiscl1"><h2 class="pmc_sec_title">Publisher’s Note</h2>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>We acknowledge the statistical assistance provided by the Center of Statistical Consultation and Research in the Department of Medical Research, National Taiwan University Hospital. We would like to express our thanks to the staff of the Department of Medical Research for providing the clinical data from the National Taiwan University Hospital-integrated Medical Database (NTUH-iMD).</p></section><section id="S9"><h2 class="pmc_sec_title">Funding</h2>
<p>This study was supported by grants from the Ministry of Science and Technology, Taiwan to S-TH (108-2321-B-002-068, 109-2320-B-002-025) and C-CC (109-2320-B-002-024), from the National Taiwan University Hospital to S-TH (UN110-014), and from the Ministry of Education to S-TH (107L9014-2).</p></section><section id="S11"><h2 class="pmc_sec_title">Supplementary Material</h2>
<p>The Supplementary Material for this article can be found online at: <a href="https://www.frontiersin.org/articles/10.3389/fnagi.2021.786322/full#supplementary-material" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.frontiersin.org/articles/10.3389/fnagi.2021.786322/full#supplementary-material</a></p>
<section class="sm xbox font-sm" id="TS1"><div class="media p"><div class="caption">
<a href="/articles/instance/8826435/bin/Table_1.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (20.4KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="DS1"><div class="media p"><div class="caption">
<a href="/articles/instance/8826435/bin/Data_Sheet_1.PDF" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (703.6KB, PDF) </sup>
</div></div></section></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ol class="ref-list font-sm">
<li id="B1">
<cite>Adams D., Coelho T., Obici L., Merlini G., Mincheva Z., Suanprasert N., et al.  (2015). Rapid progression of familial amyloidotic polyneuropathy: a multinational natural history study.
<em>Neurology</em>
85
675–682. 10.1212/WNL.0000000000001870
</cite> [<a href="https://doi.org/10.1212/WNL.0000000000001870" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4553033/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26208957/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Rapid%20progression%20of%20familial%20amyloidotic%20polyneuropathy:%20a%20multinational%20natural%20history%20study.&amp;author=D.%20Adams&amp;author=T.%20Coelho&amp;author=L.%20Obici&amp;author=G.%20Merlini&amp;author=Z.%20Mincheva&amp;volume=85&amp;publication_year=2015&amp;pages=675-682&amp;pmid=26208957&amp;doi=10.1212/WNL.0000000000001870&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2">
<cite>Adams D., Gonzalez-Duarte A., O’Riordan W. D., Yang C. C., Ueda M., Kristen A. V., et al.  (2018). Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis.
<em>N. Engl. J. Med.</em>
379
11–21.</cite> [<a href="https://doi.org/10.1056/NEJMoa1716153" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29972753/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N.%20Engl.%20J.%20Med.&amp;title=Patisiran,%20an%20RNAi%20therapeutic,%20for%20hereditary%20transthyretin%20amyloidosis.&amp;author=D.%20Adams&amp;author=A.%20Gonzalez-Duarte&amp;author=W.%20D.%20O%E2%80%99Riordan&amp;author=C.%20C.%20Yang&amp;author=M.%20Ueda&amp;volume=379&amp;publication_year=2018&amp;pages=11-21&amp;pmid=29972753&amp;doi=10.1056/NEJMoa1716153&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3">
<cite>Adams D., Koike H., Slama M., Coelho T. (2019). Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease.
<em>Nat. Rev. Neurol.</em>
15
387–404. 10.1038/s41582-019-0210-4
</cite> [<a href="https://doi.org/10.1038/s41582-019-0210-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31209302/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Neurol.&amp;title=Hereditary%20transthyretin%20amyloidosis:%20a%20model%20of%20medical%20progress%20for%20a%20fatal%20disease.&amp;author=D.%20Adams&amp;author=H.%20Koike&amp;author=M.%20Slama&amp;author=T.%20Coelho&amp;volume=15&amp;publication_year=2019&amp;pages=387-404&amp;pmid=31209302&amp;doi=10.1038/s41582-019-0210-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4">
<cite>Adams D., Suhr O. B., Hund E., Obici L., Tournev I., Campistol J. M., et al.  (2016). First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy.
<em>Curr. Opin. Neurol.</em>
29 (Suppl. 1), S14–S26. 10.1097/WCO.0000000000000289
</cite> [<a href="https://doi.org/10.1097/WCO.0000000000000289" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4739312/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26734952/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr.%20Opin.%20Neurol.&amp;title=First%20European%20consensus%20for%20diagnosis,%20management,%20and%20treatment%20of%20transthyretin%20familial%20amyloid%20polyneuropathy.&amp;author=D.%20Adams&amp;author=O.%20B.%20Suhr&amp;author=E.%20Hund&amp;author=L.%20Obici&amp;author=I.%20Tournev&amp;volume=29&amp;issue=Suppl.%201&amp;publication_year=2016&amp;pages=S14-S26&amp;pmid=26734952&amp;doi=10.1097/WCO.0000000000000289&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5">
<cite>Ando Y., Coelho T., Berk J. L., Cruz M. W., Ericzon B. G., Ikeda S., et al.  (2013). Guideline of transthyretin-related hereditary amyloidosis for clinicians.
<em>Orphanet J. Rare Dis.</em>
8:31. 10.1186/1750-1172-8-31
</cite> [<a href="https://doi.org/10.1186/1750-1172-8-31" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3584981/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23425518/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Orphanet%20J.%20Rare%20Dis.&amp;title=Guideline%20of%20transthyretin-related%20hereditary%20amyloidosis%20for%20clinicians.&amp;author=Y.%20Ando&amp;author=T.%20Coelho&amp;author=J.%20L.%20Berk&amp;author=M.%20W.%20Cruz&amp;author=B.%20G.%20Ericzon&amp;volume=8&amp;publication_year=2013&amp;pages=31&amp;pmid=23425518&amp;doi=10.1186/1750-1172-8-31&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6">
<cite>Benson M. D., Buxbaum J. N., Eisenberg D. S., Merlini G., Saraiva M. J. M., Sekijima Y., et al.  (2020). Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee.
<em>Amyloid</em>
27
217–222. 10.1080/13506129.2020.1835263
</cite> [<a href="https://doi.org/10.1080/13506129.2020.1835263" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33100054/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid&amp;title=Amyloid%20nomenclature%202020:%20update%20and%20recommendations%20by%20the%20International%20Society%20of%20Amyloidosis%20(ISA)%20nomenclature%20committee.&amp;author=M.%20D.%20Benson&amp;author=J.%20N.%20Buxbaum&amp;author=D.%20S.%20Eisenberg&amp;author=G.%20Merlini&amp;author=M.%20J.%20M.%20Saraiva&amp;volume=27&amp;publication_year=2020&amp;pages=217-222&amp;pmid=33100054&amp;doi=10.1080/13506129.2020.1835263&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7">
<cite>Benson M. D., Waddington-Cruz M., Berk J. L., Polydefkis M., Dyck P. J., Wang A. K., et al.  (2018). Inotersen treatment for patients with hereditary transthyretin amyloidosis.
<em>N. Engl. J. Med.</em>
379
22–31.</cite> [<a href="https://doi.org/10.1056/NEJMoa1716793" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12611561/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29972757/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N.%20Engl.%20J.%20Med.&amp;title=Inotersen%20treatment%20for%20patients%20with%20hereditary%20transthyretin%20amyloidosis.&amp;author=M.%20D.%20Benson&amp;author=M.%20Waddington-Cruz&amp;author=J.%20L.%20Berk&amp;author=M.%20Polydefkis&amp;author=P.%20J.%20Dyck&amp;volume=379&amp;publication_year=2018&amp;pages=22-31&amp;pmid=29972757&amp;doi=10.1056/NEJMoa1716793&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8">
<cite>Berk J. L., Suhr O. B., Obici L., Sekijima Y., Zeldenrust S. R., Yamashita T., et al.  (2013). Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial.
<em>JAMA</em>
310
2658–2667. 10.1001/jama.2013.283815
</cite> [<a href="https://doi.org/10.1001/jama.2013.283815" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4139164/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24368466/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Repurposing%20diflunisal%20for%20familial%20amyloid%20polyneuropathy:%20a%20randomized%20clinical%20trial.&amp;author=J.%20L.%20Berk&amp;author=O.%20B.%20Suhr&amp;author=L.%20Obici&amp;author=Y.%20Sekijima&amp;author=S.%20R.%20Zeldenrust&amp;volume=310&amp;publication_year=2013&amp;pages=2658-2667&amp;pmid=24368466&amp;doi=10.1001/jama.2013.283815&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9">
<cite>Bjerle P., Ek B., Linderholm H., Steen L. (1993). Oesophageal dysfunction in familial amyloidosis with polyneuropathy.
<em>Clin. Physiol.</em>
13
57–69. 10.1111/j.1475-097x.1993.tb00317.x
</cite> [<a href="https://doi.org/10.1111/j.1475-097x.1993.tb00317.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8435977/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Physiol.&amp;title=Oesophageal%20dysfunction%20in%20familial%20amyloidosis%20with%20polyneuropathy.&amp;author=P.%20Bjerle&amp;author=B.%20Ek&amp;author=H.%20Linderholm&amp;author=L.%20Steen&amp;volume=13&amp;publication_year=1993&amp;pages=57-69&amp;pmid=8435977&amp;doi=10.1111/j.1475-097x.1993.tb00317.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10">
<cite>Buades-Reinés J., Raya-Cruz M., Gallego-Lezaún C., Ripoll-Vera T., Usón-Martín M., Andreu-Serra H., et al.  (2016). Transthyretin familial amyloid polyneuropathy (TTR-FAP) in Mallorca: a comparison between late- and early-onset disease.
<em>J. Peripher. Nerv. Syst.</em>
21
352–356. 10.1111/jns.12180
</cite> [<a href="https://doi.org/10.1111/jns.12180" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27403623/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Peripher.%20Nerv.%20Syst.&amp;title=Transthyretin%20familial%20amyloid%20polyneuropathy%20(TTR-FAP)%20in%20Mallorca:%20a%20comparison%20between%20late-%20and%20early-onset%20disease.&amp;author=J.%20Buades-Rein%C3%A9s&amp;author=M.%20Raya-Cruz&amp;author=C.%20Gallego-Leza%C3%BAn&amp;author=T.%20Ripoll-Vera&amp;author=M.%20Us%C3%B3n-Mart%C3%ADn&amp;volume=21&amp;publication_year=2016&amp;pages=352-356&amp;pmid=27403623&amp;doi=10.1111/jns.12180&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11">
<cite>Carr A. S., Pelayo-Negro A. L., Evans M. R., Laurà M., Blake J., Stancanelli C., et al.  (2016). A study of the neuropathy associated with transthyretin amyloidosis (ATTR) in the UK.
<em>J. Neurol. Neurosurg. Psychiatry</em>
87
620–627. 10.1136/jnnp-2015-310907
</cite> [<a href="https://doi.org/10.1136/jnnp-2015-310907" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26243339/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Neurol.%20Neurosurg.%20Psychiatry&amp;title=A%20study%20of%20the%20neuropathy%20associated%20with%20transthyretin%20amyloidosis%20(ATTR)%20in%20the%20UK.&amp;author=A.%20S.%20Carr&amp;author=A.%20L.%20Pelayo-Negro&amp;author=M.%20R.%20Evans&amp;author=M.%20Laur%C3%A0&amp;author=J.%20Blake&amp;volume=87&amp;publication_year=2016&amp;pages=620-627&amp;pmid=26243339&amp;doi=10.1136/jnnp-2015-310907&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12">
<cite>Castaño A., Helmke S., Alvarez J., Delisle S., Maurer M. S. (2012). Diflunisal for ATTR cardiac amyloidosis.
<em>Congest Heart Fail</em>
18
315–319. 10.1111/j.1751-7133.2012.00303.x
</cite> [<a href="https://doi.org/10.1111/j.1751-7133.2012.00303.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3727153/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22747647/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Congest%20Heart%20Fail&amp;title=Diflunisal%20for%20ATTR%20cardiac%20amyloidosis.&amp;author=A.%20Casta%C3%B1o&amp;author=S.%20Helmke&amp;author=J.%20Alvarez&amp;author=S.%20Delisle&amp;author=M.%20S.%20Maurer&amp;volume=18&amp;publication_year=2012&amp;pages=315-319&amp;pmid=22747647&amp;doi=10.1111/j.1751-7133.2012.00303.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13">
<cite>Chao H. C., Liao Y. C., Liu Y. T., Guo Y. C., Chang F. P., Lee Y. C., et al.  (2019). Clinical and genetic profiles of hereditary transthyretin amyloidosis in Taiwan.
<em>Ann. Clin. Transl. Neurol.</em>
6
913–922. 10.1002/acn3.778
</cite> [<a href="https://doi.org/10.1002/acn3.778" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6529922/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31139689/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann.%20Clin.%20Transl.%20Neurol.&amp;title=Clinical%20and%20genetic%20profiles%20of%20hereditary%20transthyretin%20amyloidosis%20in%20Taiwan.&amp;author=H.%20C.%20Chao&amp;author=Y.%20C.%20Liao&amp;author=Y.%20T.%20Liu&amp;author=Y.%20C.%20Guo&amp;author=F.%20P.%20Chang&amp;volume=6&amp;publication_year=2019&amp;pages=913-922&amp;pmid=31139689&amp;doi=10.1002/acn3.778&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14">
<cite>Chiang H. Y., Chien H. F., Shen H. H., Yang J. D., Chen Y. H., Chen J. H., et al.  (2005). Reinnervation of muscular targets by nerve regeneration through guidance conduits.
<em>J. Neuropathol. Exp. Neurol.</em>
64
576–587. 10.1097/01.jnen.0000171654.24836.bd
</cite> [<a href="https://doi.org/10.1097/01.jnen.0000171654.24836.bd" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16042309/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Neuropathol.%20Exp.%20Neurol.&amp;title=Reinnervation%20of%20muscular%20targets%20by%20nerve%20regeneration%20through%20guidance%20conduits.&amp;author=H.%20Y.%20Chiang&amp;author=H.%20F.%20Chien&amp;author=H.%20H.%20Shen&amp;author=J.%20D.%20Yang&amp;author=Y.%20H.%20Chen&amp;volume=64&amp;publication_year=2005&amp;pages=576-587&amp;pmid=16042309&amp;doi=10.1097/01.jnen.0000171654.24836.bd&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15">
<cite>Chiang M. C., Yeh T. Y., Sung J. Y., Hsueh H. W., Kao Y. H., Hsueh S. J., et al.  (2021). Early changes of nerve integrity in preclinical carriers of hereditary transthyretin Ala117Ser amyloidosis with polyneuropathy.
<em>Eur. J. Neurol.</em>
28
982–991. 10.1111/ene.14698
</cite> [<a href="https://doi.org/10.1111/ene.14698" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33369810/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Neurol.&amp;title=Early%20changes%20of%20nerve%20integrity%20in%20preclinical%20carriers%20of%20hereditary%20transthyretin%20Ala117Ser%20amyloidosis%20with%20polyneuropathy.&amp;author=M.%20C.%20Chiang&amp;author=T.%20Y.%20Yeh&amp;author=J.%20Y.%20Sung&amp;author=H.%20W.%20Hsueh&amp;author=Y.%20H.%20Kao&amp;volume=28&amp;publication_year=2021&amp;pages=982-991&amp;pmid=33369810&amp;doi=10.1111/ene.14698&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16">
<cite>Coelho T., Inês M., Conceição I., Soares M., de Carvalho M., Costa J. (2018). Natural history and survival in stage 1 Val30Met transthyretin familial amyloid polyneuropathy.
<em>Neurology</em>
91
e1999–e2009.</cite> [<a href="https://doi.org/10.1212/WNL.0000000000006543" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30333157/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Natural%20history%20and%20survival%20in%20stage%201%20Val30Met%20transthyretin%20familial%20amyloid%20polyneuropathy.&amp;author=T.%20Coelho&amp;author=M.%20In%C3%AAs&amp;author=I.%20Concei%C3%A7%C3%A3o&amp;author=M.%20Soares&amp;author=M.%20de%20Carvalho&amp;volume=91&amp;publication_year=2018&amp;pages=e1999-e2009&amp;pmid=30333157&amp;doi=10.1212/WNL.0000000000006543&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17">
<cite>Conceição I., De Carvalho M. (2007). Clinical variability in type I familial amyloid polyneuropathy (Val30Met): comparison between late- and early-onset cases in Portugal.
<em>Muscle Nerve</em>
35
116–118. 10.1002/mus.20644
</cite> [<a href="https://doi.org/10.1002/mus.20644" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16969832/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Muscle%20Nerve&amp;title=Clinical%20variability%20in%20type%20I%20familial%20amyloid%20polyneuropathy%20(Val30Met):%20comparison%20between%20late-%20and%20early-onset%20cases%20in%20Portugal.&amp;author=I.%20Concei%C3%A7%C3%A3o&amp;author=M.%20De%20Carvalho&amp;volume=35&amp;publication_year=2007&amp;pages=116-118&amp;pmid=16969832&amp;doi=10.1002/mus.20644&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18">
<cite>Damy T., Kristen A. V., Suhr O. B., Maurer M. S., Planté-Bordeneuve V., Yu C. R., et al.  (2019). Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS).
<em>Eur. Heart J.</em> Online ahead of print. 10.1093/eurheartj/ehz173
</cite> [<a href="https://doi.org/10.1093/eurheartj/ehz173" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8825236/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30938420/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20Heart%20J.&amp;title=Transthyretin%20cardiac%20amyloidosis%20in%20continental%20Western%20Europe:%20an%20insight%20through%20the%20Transthyretin%20Amyloidosis%20Outcomes%20Survey%20(THAOS).&amp;author=T.%20Damy&amp;author=A.%20V.%20Kristen&amp;author=O.%20B.%20Suhr&amp;author=M.%20S.%20Maurer&amp;author=V.%20Plant%C3%A9-Bordeneuve&amp;publication_year=2019&amp;pmid=30938420&amp;doi=10.1093/eurheartj/ehz173&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19">
<cite>Dang J., Abulizi M., Moktefi A., El Karoui K., Deux J. F., Bodez D., et al.  (2019). Renal infarction and its consequences for renal function in patients with cardiac amyloidosis.
<em>Mayo Clin. Proc.</em>
94
961–975. 10.1016/j.mayocp.2019.02.012
</cite> [<a href="https://doi.org/10.1016/j.mayocp.2019.02.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31103217/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mayo%20Clin.%20Proc.&amp;title=Renal%20infarction%20and%20its%20consequences%20for%20renal%20function%20in%20patients%20with%20cardiac%20amyloidosis.&amp;author=J.%20Dang&amp;author=M.%20Abulizi&amp;author=A.%20Moktefi&amp;author=K.%20El%20Karoui&amp;author=J.%20F.%20Deux&amp;volume=94&amp;publication_year=2019&amp;pages=961-975&amp;pmid=31103217&amp;doi=10.1016/j.mayocp.2019.02.012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20">
<cite>Dohrn M. F., Röcken C., De Bleecker J. L., Martin J. J., Vorgerd M., Van den Bergh P. Y., et al.  (2013). Diagnostic hallmarks and pitfalls in late-onset progressive transthyretin-related amyloid-neuropathy.
<em>J. Neurol.</em>
260
3093–3108. 10.1007/s00415-013-7124-7
</cite> [<a href="https://doi.org/10.1007/s00415-013-7124-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24101130/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Neurol.&amp;title=Diagnostic%20hallmarks%20and%20pitfalls%20in%20late-onset%20progressive%20transthyretin-related%20amyloid-neuropathy.&amp;author=M.%20F.%20Dohrn&amp;author=C.%20R%C3%B6cken&amp;author=J.%20L.%20De%20Bleecker&amp;author=J.%20J.%20Martin&amp;author=M.%20Vorgerd&amp;volume=260&amp;publication_year=2013&amp;pages=3093-3108&amp;pmid=24101130&amp;doi=10.1007/s00415-013-7124-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21">
<cite>Du K., Li F., Wang H., Miao Y., Lv H., Zhang W., et al.  (2021). Hereditary transthyretin amyloidosis in mainland China: a unicentric retrospective study.
<em>Ann. Clin. Transl. Neurol.</em>
8
831–841. 10.1002/acn3.51328
</cite> [<a href="https://doi.org/10.1002/acn3.51328" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8045954/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33739616/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann.%20Clin.%20Transl.%20Neurol.&amp;title=Hereditary%20transthyretin%20amyloidosis%20in%20mainland%20China:%20a%20unicentric%20retrospective%20study.&amp;author=K.%20Du&amp;author=F.%20Li&amp;author=H.%20Wang&amp;author=Y.%20Miao&amp;author=H.%20Lv&amp;volume=8&amp;publication_year=2021&amp;pages=831-841&amp;pmid=33739616&amp;doi=10.1002/acn3.51328&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22">
<cite>Dumitru D., Amato A., Zwarts M. (2002). <em>Electrodiagnostic Medicine</em>, 2nd Edn. Philadelphia, PA: Hanley &amp; Belfus.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Electrodiagnostic%20Medicine&amp;author=D.%20Dumitru&amp;author=A.%20Amato&amp;author=M.%20Zwarts&amp;publication_year=2002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23">
<cite>Gioeva Z., Urban P., Meliss R. R., Haag J., Axmann H. D., Siebert F., et al.  (2013). ATTR amyloid in the carpal tunnel ligament is frequently of wildtype transthyretin origin.
<em>Amyloid</em>
20
1–6. 10.3109/13506129.2012.750604
</cite> [<a href="https://doi.org/10.3109/13506129.2012.750604" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23244293/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid&amp;title=ATTR%20amyloid%20in%20the%20carpal%20tunnel%20ligament%20is%20frequently%20of%20wildtype%20transthyretin%20origin.&amp;author=Z.%20Gioeva&amp;author=P.%20Urban&amp;author=R.%20R.%20Meliss&amp;author=J.%20Haag&amp;author=H.%20D.%20Axmann&amp;volume=20&amp;publication_year=2013&amp;pages=1-6&amp;pmid=23244293&amp;doi=10.3109/13506129.2012.750604&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24">
<cite>Gonçalves I., Alves C. H., Quintela T., Baltazar G., Socorro S., Saraiva M. J., et al.  (2008). Transthyretin is up-regulated by sex hormones in mice liver.
<em>Mol. Cell Biochem.</em>
317
137–142. 10.1007/s11010-008-9841-2
</cite> [<a href="https://doi.org/10.1007/s11010-008-9841-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18568387/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Cell%20Biochem.&amp;title=Transthyretin%20is%20up-regulated%20by%20sex%20hormones%20in%20mice%20liver.&amp;author=I.%20Gon%C3%A7alves&amp;author=C.%20H.%20Alves&amp;author=T.%20Quintela&amp;author=G.%20Baltazar&amp;author=S.%20Socorro&amp;volume=317&amp;publication_year=2008&amp;pages=137-142&amp;pmid=18568387&amp;doi=10.1007/s11010-008-9841-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25">
<cite>Groothof D., Nienhuis H. L. A., Bijzet J., Houwerzijl E. J., van den Berg M. P., Glaudemans A., et al.  (2020). Regression of bone-tracer uptake in cardiac transthyretin amyloidosis.
<em>Mayo Clin. Proc.</em>
95
417–418. 10.1016/j.mayocp.2019.10.036
</cite> [<a href="https://doi.org/10.1016/j.mayocp.2019.10.036" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31883697/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mayo%20Clin.%20Proc.&amp;title=Regression%20of%20bone-tracer%20uptake%20in%20cardiac%20transthyretin%20amyloidosis.&amp;author=D.%20Groothof&amp;author=H.%20L.%20A.%20Nienhuis&amp;author=J.%20Bijzet&amp;author=E.%20J.%20Houwerzijl&amp;author=M.%20P.%20van%20den%20Berg&amp;volume=95&amp;publication_year=2020&amp;pages=417-418&amp;pmid=31883697&amp;doi=10.1016/j.mayocp.2019.10.036&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26">
<cite>Ikeda K., Kinoshita M., Takamiya K., Iwasaki Y., Tomita Y., Nakano I. I., et al.  (1998). Bulbar palsy in senile onset familial amyloid polyneuropathy (30Val–&gt;Met): transthyretin-amyloid deposits in the hypoglossal nerve root.
<em>Eur. J. Neurol.</em>
5
211–214. 10.1046/j.1468-1331.1998.520211.x
</cite> [<a href="https://doi.org/10.1046/j.1468-1331.1998.520211.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10210834/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Neurol.&amp;title=Bulbar%20palsy%20in%20senile%20onset%20familial%20amyloid%20polyneuropathy%20(30Val%E2%80%93&gt;Met):%20transthyretin-amyloid%20deposits%20in%20the%20hypoglossal%20nerve%20root.&amp;author=K.%20Ikeda&amp;author=M.%20Kinoshita&amp;author=K.%20Takamiya&amp;author=Y.%20Iwasaki&amp;author=Y.%20Tomita&amp;volume=5&amp;publication_year=1998&amp;pages=211-214&amp;pmid=10210834&amp;doi=10.1046/j.1468-1331.1998.520211.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27">
<cite>Ikeda S., Nakazato M., Ando Y., Sobue G. (2002). Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity.
<em>Neurology</em>
58
1001–1007. 10.1212/wnl.58.7.1001
</cite> [<a href="https://doi.org/10.1212/wnl.58.7.1001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11940682/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Familial%20transthyretin-type%20amyloid%20polyneuropathy%20in%20Japan:%20clinical%20and%20genetic%20heterogeneity.&amp;author=S.%20Ikeda&amp;author=M.%20Nakazato&amp;author=Y.%20Ando&amp;author=G.%20Sobue&amp;volume=58&amp;publication_year=2002&amp;pages=1001-1007&amp;pmid=11940682&amp;doi=10.1212/wnl.58.7.1001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28">
<cite>Koike H., Kiuchi T., Iijima M., Ueda M., Ando Y., Morozumi S., et al.  (2011). Systemic but asymptomatic transthyretin amyloidosis 8 years after domino liver transplantation.
<em>J. Neurol. Neurosurg. Psychiatry</em>
82
1287–1290. 10.1136/jnnp.2010.218958
</cite> [<a href="https://doi.org/10.1136/jnnp.2010.218958" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20935325/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Neurol.%20Neurosurg.%20Psychiatry&amp;title=Systemic%20but%20asymptomatic%20transthyretin%20amyloidosis%208%20years%20after%20domino%20liver%20transplantation.&amp;author=H.%20Koike&amp;author=T.%20Kiuchi&amp;author=M.%20Iijima&amp;author=M.%20Ueda&amp;author=Y.%20Ando&amp;volume=82&amp;publication_year=2011&amp;pages=1287-1290&amp;pmid=20935325&amp;doi=10.1136/jnnp.2010.218958&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29">
<cite>Koike H., Misu K., Ikeda S., Ando Y., Nakazato M., Ando E., et al.  (2002). Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- vs late-onset form.
<em>Arch. Neurol.</em>
59
1771–1776. 10.1001/archneur.59.11.1771
</cite> [<a href="https://doi.org/10.1001/archneur.59.11.1771" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12433265/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arch.%20Neurol.&amp;title=Type%20I%20(transthyretin%20Met30)%20familial%20amyloid%20polyneuropathy%20in%20Japan:%20early-%20vs%20late-onset%20form.&amp;author=H.%20Koike&amp;author=K.%20Misu&amp;author=S.%20Ikeda&amp;author=Y.%20Ando&amp;author=M.%20Nakazato&amp;volume=59&amp;publication_year=2002&amp;pages=1771-1776&amp;pmid=12433265&amp;doi=10.1001/archneur.59.11.1771&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30">
<cite>Koike H., Misu K., Sugiura M., Iijima M., Mori K., Yamamoto M., et al.  (2004). Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy.
<em>Neurology</em>
63
129–138. 10.1212/01.wnl.0000132966.36437.12
</cite> [<a href="https://doi.org/10.1212/01.wnl.0000132966.36437.12" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15249622/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Pathology%20of%20early-%20vs%20late-onset%20TTR%20Met30%20familial%20amyloid%20polyneuropathy.&amp;author=H.%20Koike&amp;author=K.%20Misu&amp;author=M.%20Sugiura&amp;author=M.%20Iijima&amp;author=K.%20Mori&amp;volume=63&amp;publication_year=2004&amp;pages=129-138&amp;pmid=15249622&amp;doi=10.1212/01.wnl.0000132966.36437.12&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B31">
<cite>Koike H., Tanaka F., Hashimoto R., Tomita M., Kawagashira Y., Iijima M., et al.  (2012). Natural history of transthyretin Val30Met familial amyloid polyneuropathy: analysis of late-onset cases from non-endemic areas.
<em>J. Neurol. Neurosurg. Psychiatry</em>
83
152–158. 10.1136/jnnp-2011-301299
</cite> [<a href="https://doi.org/10.1136/jnnp-2011-301299" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22228785/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Neurol.%20Neurosurg.%20Psychiatry&amp;title=Natural%20history%20of%20transthyretin%20Val30Met%20familial%20amyloid%20polyneuropathy:%20analysis%20of%20late-onset%20cases%20from%20non-endemic%20areas.&amp;author=H.%20Koike&amp;author=F.%20Tanaka&amp;author=R.%20Hashimoto&amp;author=M.%20Tomita&amp;author=Y.%20Kawagashira&amp;volume=83&amp;publication_year=2012&amp;pages=152-158&amp;pmid=22228785&amp;doi=10.1136/jnnp-2011-301299&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B32">
<cite>Lane T., Fontana M., Martinez-Naharro A., Quarta C. C., Whelan C. J., Petrie A., et al.  (2019). Natural history, quality of life, and outcome in cardiac transthyretin amyloidosis.
<em>Circulation</em>
140
16–26.</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.118.038169" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31109193/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Natural%20history,%20quality%20of%20life,%20and%20outcome%20in%20cardiac%20transthyretin%20amyloidosis.&amp;author=T.%20Lane&amp;author=M.%20Fontana&amp;author=A.%20Martinez-Naharro&amp;author=C.%20C.%20Quarta&amp;author=C.%20J.%20Whelan&amp;volume=140&amp;publication_year=2019&amp;pages=16-26&amp;pmid=31109193&amp;doi=10.1161/CIRCULATIONAHA.118.038169&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B33">
<cite>Low S. C., Tan C. Y., Md Sari N. A., Ahmad-Annuar A., Wong K. T., Lin K. P., et al.  (2019). Ala97Ser mutation is common among ethnic Chinese Malaysians with transthyretin familial amyloid polyneuropathy.
<em>Amyloid</em>
26
7–8. 10.1080/13506129.2019.1582479
</cite> [<a href="https://doi.org/10.1080/13506129.2019.1582479" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31343308/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid&amp;title=Ala97Ser%20mutation%20is%20common%20among%20ethnic%20Chinese%20Malaysians%20with%20transthyretin%20familial%20amyloid%20polyneuropathy.&amp;author=S.%20C.%20Low&amp;author=C.%20Y.%20Tan&amp;author=N.%20A.%20Md%20Sari&amp;author=A.%20Ahmad-Annuar&amp;author=K.%20T.%20Wong&amp;volume=26&amp;publication_year=2019&amp;pages=7-8&amp;pmid=31343308&amp;doi=10.1080/13506129.2019.1582479&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B34">
<cite>Mariani L. L., Lozeron P., Théaudin M., Mincheva Z., Signate A., Ducot B., et al.  (2015). Genotype-phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France.
<em>Ann. Neurol.</em>
78
901–916. 10.1002/ana.24519
</cite> [<a href="https://doi.org/10.1002/ana.24519" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4738459/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26369527/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann.%20Neurol.&amp;title=Genotype-phenotype%20correlation%20and%20course%20of%20transthyretin%20familial%20amyloid%20polyneuropathies%20in%20France.&amp;author=L.%20L.%20Mariani&amp;author=P.%20Lozeron&amp;author=M.%20Th%C3%A9audin&amp;author=Z.%20Mincheva&amp;author=A.%20Signate&amp;volume=78&amp;publication_year=2015&amp;pages=901-916&amp;pmid=26369527&amp;doi=10.1002/ana.24519&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B35">
<cite>Maurer M. S., Schwartz J. H., Gundapaneni B., Elliott P. M., Merlini G., Waddington-Cruz M., et al.  (2018). Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy.
<em>N. Engl. J. Med.</em>
379
1007–1016.</cite> [<a href="https://doi.org/10.1056/NEJMoa1805689" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30145929/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N.%20Engl.%20J.%20Med.&amp;title=Tafamidis%20treatment%20for%20patients%20with%20transthyretin%20amyloid%20cardiomyopathy.&amp;author=M.%20S.%20Maurer&amp;author=J.%20H.%20Schwartz&amp;author=B.%20Gundapaneni&amp;author=P.%20M.%20Elliott&amp;author=G.%20Merlini&amp;volume=379&amp;publication_year=2018&amp;pages=1007-1016&amp;pmid=30145929&amp;doi=10.1056/NEJMoa1805689&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B36">
<cite>Milandri A., Farioli A., Gagliardi C., Longhi S., Salvi F., Curti S., et al.  (2020). Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies.
<em>Eur. J. Heart Fail</em>
22
507–515. 10.1002/ejhf.1742
</cite> [<a href="https://doi.org/10.1002/ejhf.1742" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31975495/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Heart%20Fail&amp;title=Carpal%20tunnel%20syndrome%20in%20cardiac%20amyloidosis:%20implications%20for%20early%20diagnosis%20and%20prognostic%20role%20across%20the%20spectrum%20of%20aetiologies.&amp;author=A.%20Milandri&amp;author=A.%20Farioli&amp;author=C.%20Gagliardi&amp;author=S.%20Longhi&amp;author=F.%20Salvi&amp;volume=22&amp;publication_year=2020&amp;pages=507-515&amp;pmid=31975495&amp;doi=10.1002/ejhf.1742&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B37">
<cite>Monteiro C., Magalhães M., Correia C., Taipa R. (2012). Permanent dysphagia in familial amyloid polyneuropathy (ATTRVal30Met).
<em>Amyloid</em>
19
110–112. 10.3109/13506129.2012.661806
</cite> [<a href="https://doi.org/10.3109/13506129.2012.661806" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22385252/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid&amp;title=Permanent%20dysphagia%20in%20familial%20amyloid%20polyneuropathy%20(ATTRVal30Met).&amp;author=C.%20Monteiro&amp;author=M.%20Magalh%C3%A3es&amp;author=C.%20Correia&amp;author=R.%20Taipa&amp;volume=19&amp;publication_year=2012&amp;pages=110-112&amp;pmid=22385252&amp;doi=10.3109/13506129.2012.661806&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B38">
<cite>Obici L., Suhr O. B. (2019). Diagnosis and treatment of gastrointestinal dysfunction in hereditary TTR amyloidosis.
<em>Clin. Auton Res.</em>
29 (Suppl. 1), 55–63. 10.1007/s10286-019-00628-6
</cite> [<a href="https://doi.org/10.1007/s10286-019-00628-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6763516/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31452022/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Auton%20Res.&amp;title=Diagnosis%20and%20treatment%20of%20gastrointestinal%20dysfunction%20in%20hereditary%20TTR%20amyloidosis.&amp;author=L.%20Obici&amp;author=O.%20B.%20Suhr&amp;volume=29&amp;issue=Suppl.%201&amp;publication_year=2019&amp;pages=55-63&amp;pmid=31452022&amp;doi=10.1007/s10286-019-00628-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B39">
<cite>Pasutharnchat N., Taychargumpoo C., Vorasettakarnkij Y., Amornvit J. (2021). Ala97Ser transthyretin amyloidosis-associated polyneuropathy, clinical and neurophysiological profiles in a Thai cohort.
<em>BMC Neurol.</em>
21:206. 10.1186/s12883-021-02243-3
</cite> [<a href="https://doi.org/10.1186/s12883-021-02243-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8140461/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34022837/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Neurol.&amp;title=Ala97Ser%20transthyretin%20amyloidosis-associated%20polyneuropathy,%20clinical%20and%20neurophysiological%20profiles%20in%20a%20Thai%20cohort.&amp;author=N.%20Pasutharnchat&amp;author=C.%20Taychargumpoo&amp;author=Y.%20Vorasettakarnkij&amp;author=J.%20Amornvit&amp;volume=21&amp;publication_year=2021&amp;pages=206&amp;pmid=34022837&amp;doi=10.1186/s12883-021-02243-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B40">
<cite>Pinto M. V., Pinto L. F., Dias M., Rosa R. S., Mundayat R., Pedrosa R. C., et al.  (2019). Late-onset hereditary ATTR V30M amyloidosis with polyneuropathy: characterization of Brazilian subjects from the THAOS registry.
<em>J. Neurol. Sci.</em>
403
1–6. 10.1016/j.jns.2019.05.030
</cite> [<a href="https://doi.org/10.1016/j.jns.2019.05.030" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31163298/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Neurol.%20Sci.&amp;title=Late-onset%20hereditary%20ATTR%20V30M%20amyloidosis%20with%20polyneuropathy:%20characterization%20of%20Brazilian%20subjects%20from%20the%20THAOS%20registry.&amp;author=M.%20V.%20Pinto&amp;author=L.%20F.%20Pinto&amp;author=M.%20Dias&amp;author=R.%20S.%20Rosa&amp;author=R.%20Mundayat&amp;volume=403&amp;publication_year=2019&amp;pages=1-6&amp;pmid=31163298&amp;doi=10.1016/j.jns.2019.05.030&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B41">
<cite>Samões R., Taipa R., Valdrez K., Gonçalves I., Melo Pires M., Martins, et al.  (2017). Amyloid detection in the transverse carpal ligament of patients with hereditary ATTR V30M amyloidosis and carpal tunnel syndrome.
<em>Amyloid</em>
24
73–77. 10.1080/13506129.2017.1313222
</cite> [<a href="https://doi.org/10.1080/13506129.2017.1313222" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28413892/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid&amp;title=Amyloid%20detection%20in%20the%20transverse%20carpal%20ligament%20of%20patients%20with%20hereditary%20ATTR%20V30M%20amyloidosis%20and%20carpal%20tunnel%20syndrome.&amp;author=R.%20Sam%C3%B5es&amp;author=R.%20Taipa&amp;author=K.%20Valdrez&amp;author=I.%20Gon%C3%A7alves&amp;author=M.%20Melo%20Pires&amp;volume=24&amp;publication_year=2017&amp;pages=73-77&amp;pmid=28413892&amp;doi=10.1080/13506129.2017.1313222&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B42">
<cite>Sousa A., Coelho T., Barros J., Sequeiros J. (1995). Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Póvoa do Varzim and Vila do Conde (north of Portugal).
<em>Am. J. Med. Genet.</em>
60
512–521. 10.1002/ajmg.1320600606
</cite> [<a href="https://doi.org/10.1002/ajmg.1320600606" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8825887/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Med.%20Genet.&amp;title=Genetic%20epidemiology%20of%20familial%20amyloidotic%20polyneuropathy%20(FAP)-type%20I%20in%20P%C3%B3voa%20do%20Varzim%20and%20Vila%20do%20Conde%20(north%20of%20Portugal).&amp;author=A.%20Sousa&amp;author=T.%20Coelho&amp;author=J.%20Barros&amp;author=J.%20Sequeiros&amp;volume=60&amp;publication_year=1995&amp;pages=512-521&amp;pmid=8825887&amp;doi=10.1002/ajmg.1320600606&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B43">
<cite>Sridharan M., Highsmith W. E., Kurtin P. J., Zimmermann M. T., Theis J. D., Dasari S., et al.  (2018). A Patient with hereditary ATTR and a novel AGel p.Ala578Pro amyloidosis.
<em>Mayo Clin. Proc.</em>
93
1678–1682. 10.1016/j.mayocp.2018.06.016
</cite> [<a href="https://doi.org/10.1016/j.mayocp.2018.06.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30093168/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mayo%20Clin.%20Proc.&amp;title=A%20Patient%20with%20hereditary%20ATTR%20and%20a%20novel%20AGel%20p.Ala578Pro%20amyloidosis.&amp;author=M.%20Sridharan&amp;author=W.%20E.%20Highsmith&amp;author=P.%20J.%20Kurtin&amp;author=M.%20T.%20Zimmermann&amp;author=J.%20D.%20Theis&amp;volume=93&amp;publication_year=2018&amp;pages=1678-1682&amp;pmid=30093168&amp;doi=10.1016/j.mayocp.2018.06.016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B44">
<cite>Théaudin M., Lozeron P., Algalarrondo V., Lacroix C., Cauquil C., Labeyrie C., et al.  (2019). Upper limb onset of hereditary transthyretin amyloidosis is common in non-endemic areas.
<em>Eur. J. Neurol.</em>
26
497–e36. 10.1111/ene.13845
</cite> [<a href="https://doi.org/10.1111/ene.13845" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30350904/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Neurol.&amp;title=Upper%20limb%20onset%20of%20hereditary%20transthyretin%20amyloidosis%20is%20common%20in%20non-endemic%20areas.&amp;author=M.%20Th%C3%A9audin&amp;author=P.%20Lozeron&amp;author=V.%20Algalarrondo&amp;author=C.%20Lacroix&amp;author=C.%20Cauquil&amp;volume=26&amp;publication_year=2019&amp;pages=497-e36&amp;pmid=30350904&amp;doi=10.1111/ene.13845&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B45">
<cite>Yamashita T., Ueda M., Nomura T., Okazaki T., Okada M., Tsuda Y., et al.  (2019). Natural history and long-term effects of variant protein reduction in non-V30M ATTR amyloidosis.
<em>Neurology</em>
93
714–716. 10.1212/WNL.0000000000008320
</cite> [<a href="https://doi.org/10.1212/WNL.0000000000008320" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31562191/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Natural%20history%20and%20long-term%20effects%20of%20variant%20protein%20reduction%20in%20non-V30M%20ATTR%20amyloidosis.&amp;author=T.%20Yamashita&amp;author=M.%20Ueda&amp;author=T.%20Nomura&amp;author=T.%20Okazaki&amp;author=M.%20Okada&amp;volume=93&amp;publication_year=2019&amp;pages=714-716&amp;pmid=31562191&amp;doi=10.1212/WNL.0000000000008320&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ol></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/8826435/bin/Table_1.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (20.4KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/8826435/bin/Data_Sheet_1.PDF" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (703.6KB, PDF) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The datasets generated during analysis and/or during the current study are available from the corresponding author on reasonable request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Frontiers in Aging Neuroscience are provided here courtesy of <strong>Frontiers Media SA</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.3389/fnagi.2021.786322"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/fnagi-13-786322.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (4.5 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/8826435/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/8826435/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC8826435%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC8826435/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC8826435/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC8826435/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/35153720/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC8826435/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/35153720/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC8826435/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/8826435/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="tWukpubH9n51zhqSSDvrbX53yb863CCWuFh1SfzT6JkxTKJd6RA7ZBxDjZoGGcjA">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
